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ABSTRACT 
 Although severe lung disorders, including cystic fibrosis, asthma, and chronic 
obstructive pulmonary disease (COPD), represent a significant global disease burden, 
little is known about the molecular pathways by which the cells of the lung develop, 
respond to damage, or become diseased. Consequently, there are few treatment options 
for patients. Improving lung disease outcomes therefore relies on both refining the 
current understanding of the normal development of the lung epithelium and developing 
new model systems to provide mechanistic insight into disease biology.  In this thesis, I 
describe a multifaceted approach using both in vivo models and novel mouse and human 
pluripotent stem cell reporter systems to explore this important topic, focusing primarily 
on the hypothesis that canonical Wnt signaling is a key stage-dependent inhibitor of 
proximal lung development. To address this hypothesis, I developed new tools allowing 
for the precise manipulation of developmental pathways and access to rare cell 
populations in vitro. This toolkit included both mouse and human pluripotent stem cell 
(mPSC/hPSC) lines with reporters for specific airway lineages. In parallel, I built on our 
lab’s previous work in directed differentiation of hPSCs to lung progenitors. I found that 
canonical Wnt signaling regulates proximodistal epithelial patterning in human NKX2-1+ 
lung progenitors. While canonical Wnt activation is required for lung specification, 
		 ix 
withdrawal of Wnt activation leads to emergence of a proximal airway program and loss 
of distal identity. This finding culminated in the development of a novel protocol to 
differentiate epithelial-only airway organoids from hPSCs. These organoids are derived 
from purified NKX2-1+ lung progenitors, contain functional airway cell types including 
secretory, goblet, and basal cells, and can be further expanded and differentiated to 
multiciliated epithelia in air-liquid interface culture. To provide a proof of principle for 
the clinical utility of this platform, I generated airway organoids from cystic fibrosis 
patient-derived hiPSC lines pre- and post-correction of the ΔF508 mutation in the CFTR 
gene. These organoids respond in a CFTR-dependent manner to epithelial forskolin 
swelling assays, highlighting the potential utility of this approach for disease modeling 
and drug screening for a variety of genetic and acquired airway disorders. 
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I. INTRODUCTION 
I.1. Significance and Burden of Chronic Lung Disease 
 Lung disease is a leading cause of morbidity and mortality worldwide. In 
particular, diseases affecting the epithelium of the lung encompass a broad range of 
pathologies ranging from well-characterized genetic disorders such as cystic fibrosis to 
complex acquired and chronic illnesses including asthma and chronic obstructive 
pulmonary disease (COPD). Chronic lung disease alone accounts for approximately 7% 
of annual deaths worldwide1. In spite of their clinical, financial, and social burden, the 
etiology of these diverse lung diseases is poorly understood and treatment options for 
patients remain limited. Due to the complexity of these diseases and their association 
with perturbations in airway epithelial cell fate (e.g. mucus metaplasia in asthma or 
COPD) and/or hypothesized abnormal lung development2,3, improved understanding of 
how fate is established and maintained in the lung epithelium may expand insight into 
disease etiology, providing potential avenues for treatment of these disorders.  
 
I.2. Overview of Lung Development 
In complex organisms, adult tissues are formed as developing cells are 
sequentially restricted to specialized fates, beginning from the earliest stages of 
development post-fertilization until the completion of organogenesis4.  
Gastrulation and Formation of Definitive Endoderm 
Early in development (around embryonic day 3.5 in mice), the cells of the 
mammalian embryo organize into a structure known as the blastocyst, which in mammals 
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is comprised of the trophoblast, the blastocyst cavity, and the inner cell mass (ICM), the 
latter of which is the cellular source of the organs of the embryonic body4. In mammals, a 
portion of the ICM adjacent to the trophoblast will form the epiblast (also known as the 
primitive ectoderm)4. The cells of the epiblast initiate the process of gastrulation, a series 
of large-scale cell movements where cells migrate to form the three germ layers (the 
endoderm, ectoderm, and mesoderm) that will go on to form the tissues of the 
mammalian body4. One very early step in gastrulation is the formation of the primitive 
streak, the cellular source of the mesoderm and the endoderm4. This “mesendodermal” 
differentiation is regulated primarily through signaling via the TGFβ superfamily 
member nodal5. 
Endodermal fate is established and maintained in the anterior primitive streak by 
the upregulation and continued expression of key transcription factors, including Foxa26, 
Gata4, Gata67, and Sox178. During and immediately after this process, the endoderm is 
further delineated along the anterior-posterior axis based on regiospecific signals from 
the neighboring mesoderm and ectoderm into the foregut, midgut, and hindgut 
regions4,9,10. While the midgut and hindgut contribute primarily to the formation of the 
intestinal lineage, the foregut, which expresses the Sry-like HMG box transcription factor 
Sox2, gives rise to a number of organs, including the pancreas, stomach, liver, thyroid, 
esophagus, and the respiratory tract (Figure 1.1)11,12.  
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Figure 1.1. Schematic depicting formation of the gut tube. 
The foregut, which emerges from the anterior region of the definitive endoderm during 
and immediately following gastrulation, will give rise to numerous organs including the 
respiratory tract. Adapted from Zorn and Wells, 200912. 
 
Specification of the Lung Epithelium 
The respiratory lineage is specified from the Sox2+ anterior foregut at E9 in 
murine embryos and is marked by expression of the homeobox transcription factor Nkx2-
PosteriorAnterior
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1 (also known as Ttf-1)13. While Nkx2-1 is expressed in the developing thyroid and 
forebrain as well as the lung, it is the first known marker of respiratory lineage 
specification and is essential for the normal development of the lung14,15. Interestingly, 
the initiation of Nkx2-1 expression in the foregut is accompanied by a loss of Sox2 
expression that is also required for lung specification16. 
Specification of the respiratory lineage from the foregut is tightly controlled by 
crosstalk between mesodermal and endodermal tissues and is driven primarily by highly 
conserved signaling pathways including retinoic acid (RA), sonic hedgehog, Wnt and 
BMP signaling (summarized in Figure 1.2). RA signaling leads to the establishment of 
regions of lung competency within the foregut17 and stimulates the production of the 
signaling required for lung specification by inducing hedgehog ligand (Shh) expression 
by the endoderm17. This signal in turn simulates the expression of bone morphogenetic 
protein (BMP) and Wnt ligands by the adjacent mesenchyme and endoderm17, each of 
which functions as a key inductive signal for lung specification. 
Expression of mesodermal BMP4 initiates BMP signaling via Bmpr1a and 1b in 
the foregut endoderm. Mutant mice lacking Bmpr1a and 1b in the ventral foregut 
endoderm have profound morphological lung defects and have ectopic expression of 
Sox2 in this region16. Additionally, while these mice initially undergo lung specification, 
as marked by initial (E9.25) expression of Nkx2-1, this marker is lost by E9.5 and the 
mice exhibit complete lung agenesis. Interestingly, this phenotype is rescued by 
inhibition of Sox2, implying that repression of this transcription factor is a key regulatory 
event in lung specification and is coordinated by BMP signaling16.   
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Canonical Wnt signaling is also active in the epithelium during lung specification. 
Evidence for this includes Wnt reporter activity including BAT/TOP-GAL18,19,20,21,22 and 
Axin2-LacZ21,22, staining for nuclear β-catenin19, and differential expression of TCF/LEF 
transcription factors in different regions of the developing lung18,19. Furthermore, it has 
been shown in Goss et al. that deletion of the Wnt signaling ligands Wnt 2/2b from 
mouse embryos results in complete lung agenesis with complete loss of Nkx2-1 
expression and consequent perinatal lethality. Interestingly, deletion of Wnt2 alone 
resulted in lung hypoplasia and consequent dysfunction, but no perturbation in 
proximodistal patterning, suggesting a somewhat redundant role for the Wnt2/2b ligands 
in lung specification and suggesting that the Wnt ligands involved in proximodistal 
patterning (discussed later in this introduction) are distinct from the Wnt2/2b drivers of 
specification21.  Although this study demonstrated that Wnt2/2b deletion leads to 
dramatic changes in Wnt reporter (specifically BAT-GAL) activity, contemporaneous 
work by Harris-Johnson et al. using genetic inactivation of the canonical Wnt effector 
protein β-catenin in the ventral foregut resulted in lung agenesis with accompanying 
absence of Nkx2.1 induction in the anterior foregut endoderm, again supporting the 
conclusion that canonical Wnt signaling is a key factor in lung specification21,22. 
Relatedly, Goss et al. constitutively activated Wnt signaling by deleting the regulatory 
third exon from the β-catenin gene in the ventral foregut. This resulted in expansion of 
the Nkx2-1+ lung domain into the stomach, supporting the conclusion that 
Wnt/β−catenin signaling may be sufficient to induce lung epithelial fate in some non-
lung endoderm. Interestingly, Okubo et al. showed that overexpression an activated 
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β-catenin/LEF fusion protein in the very early lung epithelium resulted in the emergence 
of cells with an intestinal-like lineage within the lung endoderm. Taken together, these 
results suggest that regional, temporal, and dose control of Wnt signaling are all critical 
to the development of a normal lung endoderm. This finding is further supported by 
studies demonstrating respiratory specification in response to Wnt activation by the small 
molecule GSK3β inhibitor CHIR99021 in mouse foregut explants17.  
Figure 1.2. Schematic of signaling pathways in lung specification.  
Illustrated here in murine development, reciprocal signals between the epithelium and the 
mesenchyme drive the specification of the Nkx2-1+ lung domain from the ventral foregut 
at the expense of Sox2 expression. Adapted from Morrisey and Hogan, 201023 and 
Rankin et al., 201617. 
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Branching Morphogenesis and Early Lung Patterning 
Immediately post-specification, the Nkx2-1+ lung domain undergoes an iterative 
process of cell division, differentiation, and movement (collectively known as branching 
morphogenesis), to form the complex respiratory tree required for functional gas 
exchange24. Much like lung specification, the process of lung branching morphogenesis 
relies on coordinated and reciprocal signaling between the epithelium and the 
neighboring mesenchyme and is mediated by numerous conserved signaling pathways 
including Wnt, FGF, BMP, TGFβ, RA, Hh,  and Notch signaling20,25-38. This process 
delineates the proximal-distal axis of the lung and drives the formation of functionally 
distinct lung compartments – the proximal conducting airways and the distal alveoli 
where gas exchange occurs. The epithelial-to-mesenchymal crosstalk necessary to control 
this process is exemplified by experiments demonstrating that recombinants of embryonic 
rat tracheal mesenchyme with distal epithelium attenuates the branching and distal 
differentiation of these cells, while distal mesenchyme can induce branching and distal 
marker expression in proximal epithelium39,40.    														
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Figure 1.3. Overview of the major stages of lung development. 
The Nkx2-1+ lung bud undergoes a process of coordinated branching and development 
regulated by multiple signaling pathways and resulting in the eventual formation of a 
branched structure of conducting airways and mature alveoli.  Adapted from Rackley & 
Stripp, 201441 
 
 
Branching morphogenesis is initiated at the distal tip of the lung bud, the 
formation and extension of which is primarily mediated by FGF signaling via FGFR2b 
ligation by FGF1030,31,42,43.  As development and branching morphogenesis proceed, the 
primordial epithelium at the distal tip experiences sequential restriction to regionalized 
(e.g. proximal vs distal) fates44. This patterning is a dynamic process characterized by 
ongoing differentiation of the multipotent Sox9+Id2+ progenitors located at the distal tip 
(Figure 1.4)45. As these cells continually divide, they alternately migrate proximally and 
contribute to the emerging airway epithelium, or continue to branch distally and 
contribute to the peripheral lung45. In later stages of development, around E13.5, the fate 
of these distal tip cells becomes further restricted to the developing alveolar 
epithelium44,45. 
review series
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day 9.5 in the mouse or week 4 in humans (7–9). The trachea, in 
contrast, is established by division of the existing foregut lumen 
into two independent luminal structures that represent the trachea 
and esophagus (10, 11). This early stage of lung development is 
referred to as the embryonic phase, the first of five phases that were 
initially defined based upon the changing morphology of develop-
ing airways (ref. 9 and Figure 1). The morphologic changes seen 
in the embryonic phase of lung development are not cell intrinsic, 
but rather mediated by diffusible signals from surrounding mes-
enchyme (12). Early endoderm isolated from surrounding mesen-
chyme loses expression of genes that mark early cell fate decisions, 
but these markers are completely restored by coculturing endo-
derm with mesenchyme and partially rescued by the addition of 
FGF4 (12). Other diffusible signals from the surrounding mesen-
chyme that have been shown to affect early embryonic cell fate deci-
sions include members of the TGF-`/bone morphogenetic protein 
(TGF-`/BMP), Hedgehog, WNT, FGF, and EGF families (12).
As lung development progresses, embryonic endoderm under-
goes progressive fate decisions that generate epithelial progeni-
tor cells with increasingly restricted developmental potential over 
time. The earliest markers of cells that distinguish future lung 
from other derivatives of the foregut endoderm include expression 
of the transcription factor Nkx2.1 and reduced expression of the 
transcription factor Sox2 (8, 10). Much like the mesenchymal inter-
actions required by the early endoderm for early differentiation, 
patterning of the lung during the process of branching morpho-
genesis is dependent on the local paracrine microenvironments, 
which differ significantly along the proximodistal axis. Grafting 
experiments using rat embryos have demonstrated that epithe-
lium from both tracheal rudiments and distal lung tips retain the 
ability to undergo either tracheal or distal lung epithelial cell dif-
ferentiation under the influence of corresponding regional embry-
onic mesoderm (13). This demonstrates that early lung endoderm 
is multipotent and that its fate is dependent upon signals provided 
by the local microenvironment (primarily mesoderm). However, 
the capacity of proximal epithelium to undergo multipotent dif-
ferentiation was lost when early embryonic distal tip mesenchyme 
was grafted adjacent to proximal epithelium of late pseudoglan-
dular stage lungs (14). The change in epithelial differentiation 
potential during the transition from pseudoglandular to cana-
licular phases of lung development reflect the progressive lineage 
restriction that occurs with advancing gestational age.
Epithelial cells start to assume differentiated characteristics 
during the pseudoglandular period of lung development. How-
ever, the precise temporospatial pattern of this process is highly 
region and cell type-specific. Some epithelial cell types, such as 
ciliated cells and neuroendocrine cells, show a proximal-to-distal 
wave of differentiation that progresses during the phase of rapid 
airway branching. FoxJ1, a marker of ciliated cell differentiation, 
first appears in the mouse trachea and large bronchial airways as 
early as E14 yet its appearance in distal bronchioles is not appar-
ent until E15.5 or later (15). Similarly, pulmonary neuroendo-
crine cells first appear as precursor cells in proximal conducting 
airways during the early pseudoglandular period of development 
and later form at the site of airway branches in more distal con-
ducting airways (16, 17). Solitary neuroendocrine precursor cells 
become innervated by ganglion cells and expand in numbers to 
generate clusters commonly referred to as neuroepithelial bodies 
Figure 1
Lung development in both mouse and human 
progresses through five overlapping phases 
based on successive branching: embryonic, 
pseudoglandular, canalicular, saccular, and 
alveolar (9). The epithelium is initially com-
posed of multipotent progenitor cells that pro-
liferate and differentiate through development 
to yield more restricted, differentiated progeny 
that make up the developed lung epithelium. 
Signaling pathways that maintain the multipo-
tent progenitor pool are indicated. HH, hedge-
hog; RA, retinoic acid.
Downloaded on January 14, 2014.   The Journal of Clinical Investigation.   More information at  www.jci.org/articles/view/60519
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In contrast to the distal tip, the developing proximal lung is characterized by 
expression of Sox2, the function of which is critical to the normal development of this 
compartment (Figure 1.4)46-48,51,49. Specifically, loss of Sox2 expression in the developing 
proximal lung leads to arrested branching morphogenesis, loss of epithelial organization 
and dramatically reduced expression of most differentiated airway markers46-48. In adult 
lungs, Sox2 is similarly critical for the maintenance of the airway and tracheal epithelia 
and regeneration of the trachea after epithelial injury48, in part because it directly 
regulates expression of the basal stem cell transcription factor p6348,50. Similarly, 
overexpression of Sox2 leads to increased proximal gene expression and airway 
expansion, even in committed distal cell types, providing more evidence that it acts as a 
key driver in the development of the airway compartment49.  
Together, Sox2 and Sox9 delineate distinct, regionalized developmental 
compartments in the murine lung and are the canonical drivers of the fate of their 
respective proximal and distal epithelia. Consequently, the signaling pathways that 
control proximodistal patterning in the lung partly function to regulate and maintain the 
spatiotemporal expression of these key transcription factors.  
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Figure 1.4. Proximodistal patterning of the developing lung. 
The multipotent distal lung epithelium (yellow) forms the tips of the branching lung and 
expresses the transcription factors Sox9 and Id2. Cells from this bud form the distal 
alveolar lung and partially contribute to the Sox2+ proximal lung until the canalicular 
stage, where they are restricted to a distal fate. In contrast, the Sox2+ proximal 
progenitors (blue) differentiate to form the diverse cells of the future airway epithelium. 	
Lung Proximodistal Patterning: FGF Signaling 
While many signaling pathways are known to contribute to lung patterning, the 
promotion of distal lung budding and differentiation by FGF signaling has been well-
characterized and this pathway has been shown to have a role as both a mitogen and in 
directing cell fate in branching morphogenesis. In addition to roles in this process for 
FGF1 and KGF (FGF7)32, it has been shown that the developing distal lung mesenchyme 
expresses high levels of FGF1031 and that FGF10-/- mice fail to undergo branching 
morphogenesis, resulting in lung agenesis30.Other reports have confirmed a mitogenic 
role for FGF10 in the process of lung branching and distal patterning, demonstrating that 
Sox2+
Sox9+
Id2+
Proximal
Distal
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culture of explanted embryonic lung endoderm adjacent to a FGF10-coated bead results 
in outgrowth of bud tips as well as expression of distal tip genes, including Sftpc28,29,31. In 
spite of these in vitro findings, however, recent work from Volckaert et al. demonstrated 
that localization of FGF signaling is not necessary for normal branching, implying that 
the canonical model of FGF10 driving bud outgrowth via localized expression in the 
budding mesenchyme may not be a complete picture of its in vivo function42. 
Related to this increasingly complex understanding of its role in development, 
FGF10 also interacts with multiple signaling pathways in the lung to help coordinate 
branching morphogenesis and proximodistal fate. For example, FGF10 is activated in 
response to Wnt signaling20,42, regiospecific Wnt inhibition by Dkk1 consequently results 
in decreased FGF10 activity42, and it has been reported that defects caused by Dkk1 
overexpression (see Wnt signaling, below) can be rescued by overexpression of FGF1042. 
Similarly, FGF signaling may also help drive canonical Wnt activation in the distal lung, 
possibly by maintaining β-catenin nuclear localization42,51. Additionally, in vitro work 
from Weaver et al. implies that FGF10 and BMP signaling interact during lung 
development; FGF10 induces BMP signaling in lung endoderm and that these signals act 
together to direct a normal branching program29.  
Lung Proximodistal Patterning: BMP signaling 
BMP signaling, like FGF10 signaling, promotes distal patterning in the lung and 
is driven primarily by BMP4 expression in the lung endoderm28,29. Inactivation of BMP 
signaling by overexpression of either Noggin or a dominant negative BMP receptor 
(Alk6) results in a complete defect in the distal lung and a loss of normal branching33. 
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Similar to its role in lung specification, it is thought that BMP4 may act in part to 
promote a distal fate by suppressing Sox2 expression34. 
Lung Proximodistal Patterning: Wnt signaling 
The functional relevance of canonical Wnt signaling in lung development has 
been demonstrated in phenotypic responses to deleting or ectopically activating canonical 
Wnt signaling in the developing lung epithelium.  
One early study testing the role of canonical Wnt signaling in lung proximodistal 
patterning was from Mucenski et al., who used a transgenic SPC-rtTA gene to drive a 
conditional, doxycycline-inducible deletion of β-catenin in the developing lungs of 
mouse embryos27. In this model, β-catenin deletion led to loss of the distal lung without 
interruption of proximal airway structures, which were abnormally expanded into the 
distal space. Concordantly, expression of proximal lung markers was observed 
throughout the lung whereas distal lung markers, including Spc, were substantially 
depleted. This finding provided key initial evidence for the hypothesis that Wnt signaling 
is critical to normal distal lung development. However, several questions remained 
unanswered. In particular, it is unclear from this model whether Wnt signaling helps to 
differentiate between proximal and distal lineages (e.g. promoting distal differentiation at 
the expense of the proximal lung), or whether it is simply necessary for maturation or 
development of distal lineages that have already been distinguished from their proximal 
counterparts. This question is of particular importance as this model relies on a driver of 
β-catenin deletion (Spc) that is after lung specification and is not expressed in the most 
proximal regions of the airways, allowing for the possibility that lung epithelial cells may 
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undergo fate decisions prior to β-catenin deletion in this model. Finally, this model is also 
unable to take into account the role of β-catenin as a key epithelial protein important to 
the normal maintenance of cellular structure. Relatedly, the authors observed structural 
changes to the mesenchyme as a result of this epithelial-only deletion of β-catenin, 
suggesting that it may be having consequences on other non-lung lineages and leading to 
difficulty in interpreting the cell fate interactions within this system. Together, these 
shortcomings point to the conclusion that, while this system provides important early 
evidence that canonical Wnt may be important for distal lung patterning, additional 
models supporting this hypothesis and testing the epithelial-specific effects of this signal 
may be informative. 
Shu et al. also tested the effect of Wnt inhibition on proximodistal patterning 
using a similar system with Spc-rtTA specifically driving the doxycycline-inducible 
expression of the Wnt inhibitor Dkk1 in the early lung epithelium20. Much like Mucenski 
et al., Shu et al. observed gross morphological abnormalities in the lung resulting from 
aberrant expansion of the airway compartment and dilation of the distal lung 
accompanied by loss of Spc expression in transgenic mice post-doxycycline treatment. 
This result has the similar shortcoming of being in a complex system with multiple 
lineages; in spite of the specificity of the rtTA expression, it is still impossible from this 
finding to dissect direct vs. indirect effects of developmental signaling due to the 
potential for tissue crosstalk. This concern is of particular interest in the context of work 
from De Langhe et al., who show that Wnt inhibition in early in vitro lung cultures by 
addition of recombinant Dkk1 leads to defects in branching, and in particular in 
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fibronectin composition, that could have important implications for downstream 
epithelial fate52. 
In spite of these ongoing complexities, the result from Shu et al. provides 
additional important insight into the potential role for Wnt in proximodistal patterning by 
demonstrating a similar effect of this pathway as Mucenski et al. using a completely 
different system with a different molecular mechanism of Wnt inhibition. 
Importantly, Shu et al. also sought to test whether this effect of Wnt signaling 
involved pathways known to regulate proximodistal patterning, including BMP signaling. 
To test this, they relied on the system described in Mucenski et al., using the doxycycline 
inducible Cre to induce mosaic airway β-catenin excision. Using this system, they 
observed downregulation of BMP4 protein in airway cells with excised β-catenin, but not 
in their neighboring β-catenin expressing cells, suggesting that Wnt acts upstream of 
BMP signaling to pattern the lung epithelium. However, they did not test whether the loss 
of distal identity in response to Wnt inhibition can be rescued by stimulation of BMP 
signaling or whether BMP signaling is a direct mediator of Wnt-driven distal patterning, 
leaving open the question as to whether these pathways perform distinct proximodistal 
patterning functions. 
Additionally, much like Mucenski et al., Shu et al. did not address whether Wnt 
signaling is critical to the decision between proximal and distal airway or if the expansion 
of proximal lineages at the expense of the distal lung in their model is due to expansion 
of pre-specified cells. As a consequence, further studies testing the effect of β-catenin 
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overexpression on lung patterning could address whether Wnt signaling suppresses 
proximal fate.  
Hashimoto et al. sought to address this question by building a system of ectopic 
overactivation of Wnt signaling through expression of an activated (N-terminally 
truncated) form of β-catenin from a transgenic Spc promoter25. They found that 
overactivation of β-catenin in this model resulted in increased activation of Wnt reporter 
systems, as expected, and led to extreme airway defects (including loss of airway cell 
types including ciliated, secretory, and basal cells) and perinatal lethality without 
disruption of the distal lung compartment. Importantly, they directly observed a loss of 
Sox2 and an expansion of Sox9 in airway cells that also stained positive for activated β-
catenin, but not in their neighboring β-catenin negative cells. Relatedly, loss of Sox2 in 
the epithelium showed a similar defect to β-catenin overexpression, further indirectly 
suggesting that this transcriptional activator may mediate the switch between these two 
key lung patterning transcription factors. Future work directly testing the interaction of 
Wnt signaling with Sox2 and Sox9 to further elucidate this relationship would be of great 
interest, in particular in the context of other pathways (such as Yap/Taz) that have been 
carefully studied as important mediators of early Sox2/Sox9 patterning and that are 
known to interact with Wnt signaling53. 
Together with the findings from Mucenski et al. and Shu et al., these works 
suggest that Wnt is a key switch that promotes distal, but inhibits proximal, fate in the 
developing lung.. 
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One important ongoing question from this work is whether Wnt signaling can 
disrupt the airway in cells that have already been patterned proximally or differentiated to 
airway lineages. To test these questions, Reynolds et al. developed a system of 
conditional stabilization of activated β-catenin in the developing airway late in gestation 
(at E16.5, following secretory cell specification) by driving excision of exon 3 of β-
catenin with a Ccsp-Cre transgene54. Using this model, they found that this stabilization 
results in a loss of secretory cell maturation and inhibition of ciliated cell differentiation, 
but results in increased proliferation of reparative secretory cells post-napthalene injury 
accompanied by increased expression of Spc, increased abundance of naphthalene-
resistant secretory cells, and loss of ciliated fate. Together, these results suggest that 
secretory cells are sensitive to Wnt signaling post-specification, and in particular that this 
signaling pathway may be tightly controlled in the context of airway repair. However, it 
is unclear whether the observed role of β-catenin-mediated signaling is the direct effect 
of this pathway or if it relies on molecular changes (e.g. Sox2 depletion) brought about as 
a downstream consequence of Wnt overactivation. Additionally, the interesting effect of 
ciliated cell depletion implies that there may be a relationship between Wnt and Notch 
signaling (the latter of which is a key negative regulator of developmental secretory vs. 
ciliated cell differentiation) in the late developing lung, a topic that would be of interest 
for further exploration. Finally, the “sledgehammer” approach of β-catenin 
overexpression used in this study without additional contextualizing experiments 
blocking Wnt in the same cells, however, makes it difficult to understand whether Wnt is 
actually important at this stage in the context of normal development. 
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This latter criticism was addressed by follow-up work from the same group, 
where Zemke et al. use Cc10-Cre-mediated deletion of β-catenin at this same stage to 
observe the effect of Wnt signaling on airway differentiation26. Somewhat in contrast to 
the conclusions of Reynolds et al,. they show that β-catenin deletion has no effect on 
airway differentiation or on epithelial repair after naphthalene injury, implying that 
canonical Wnt signaling does not have a functional role in normal airway homeostasis or 
regeneration. 
Taken together, these studies show that Wnt critically promotes distal patterning 
and inhibits proximalization during early lung development. Additionally, although Wnt 
does not have an important molecular role at later stages of airway development, aberrant 
activation of this pathway at late stages of airway development leads to changes in the 
ability of the proximal lung epithelium to mature and repair normally, implying that even 
these differentiated cells are still sensitive to downstream effects of this pathway. These 
studies also reveal a lack of understanding of the molecular mechanisms of Wnt-driven 
proximodistal patterning, in particular the stage-specific and epithelial-specific effects of 
this pathway, including the interesting hypothesis that Wnt may function as a critical 
molecular switch between Sox9+ distal and Sox2+ proximal lung fates.  
Lung Proximodistal Patterning: Retinoic acid and TGFβ signaling 
Unlike FGF10, BMP and Wnt signaling, TGFβ signaling negatively regulates 
branching and promotes a proximal lung fate, partly by regulating expression of Sox253. 
Constitutive activation of TGFβ signaling leads to a loss of branching morphogenesis and 
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abrogated distal differentiation36, whereas loss of this regulatory signal results in cystic 
branching defects and airway malformations 38. TGFβ signaling levels are partly 
controlled by RA signaling; deficiencies in RA result in considerable lung patterning 
defects and consequent agenesis linked to derepression of TGFβ35,37. This result is 
supported by the rescue of lung budding in retinoic acid-deficient embryos by repression 
of TGFβ35. Similarly, retinoic acid is also involved in activating Wnt signaling (via 
repression of Dkk1), further supporting is role as a positive regulatory signal in lung 
branching. 
Airway Epithelial Development and Differentiation 
As the lung continues to undergo proximodistal patterning, the established Sox2+ 
proximal progenitor population additionally proliferates and differentiates to mature cell 
types of the adult airway, including ciliated, secretory (also known as club, formerly 
Clara), and basal cells55. The cellular composition of the epithelium exhibits regional 
differences between the trachea and proximal conducting airways and the more distal 
terminal bronchioles and also differs between mice and humans. In mice, the trachea and 
large conducting airways comprise a pseudostratified epithelium containing basal cells, 
ciliated cells, secretory cells, rare goblet cells, and innervated neuroendocrine bodies. In 
contrast, the more distal airways contain a simple columnar epithelium lacking basal 
cells. In humans, the pseudostratified epithelium extends much more distally than in 
mice, and only the very terminal bronchioles of humans contain simple columnar 
epithelia without basal cells (Figure 1.5)41. The various cell types of the proximal lung 
have distinct functions in both lung function and repair. Functionally, the goblet, 
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secretory, and ciliated cells of the airway form a complex mucociliary escalator that helps 
to protect the lung from pathogens and other inhaled agents55. Together with stem-like 
basal cells, these facultative progenitors (secretory cells) and fully differentiated cells 
(goblet and ciliated cells) form a complex regenerative network (including both 
regenerative and terminally differentiated lineages) important to normal lung epithelial 
homeostasis as well as repair (Summarized in Figure 1.6)55. 
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Figure 1.5 Cellular composition of the airway epithelium. 
The epithelia of the mouse and human lung vary over progressive branching proximally 
to distally. The most proximal airways are characterized by a pseudostratified epithelium 
with basal, secretory, and ciliated cells, in contrast to the simple columnar distal airway. 
The distal alveolar epithelium also differs significantly from the airway and 
predominantly derives its functionality and shape from structural interactions between 
elongated type I cells and secretory type II cells. Adapted from Rackley & Stripp, 201441. 
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(17). There is some evidence that neuroepithelial bodies play 
important roles regulating the proliferation of adjacent cells dur-
ing development and serve as a focal site of secretory cell differen-
tiation in conducting airways (15, 18–20).
Epithelial cell types that appear later in development include 
secretory cells and basal cells of conducting airways, and type 1 
and type 2 pneumocytes of the alveolar epithelium. Scgb1a1, an 
early marker of secretory cell differentiation, is induced within 
subpopulations of epithelial cells in developing airways during the 
late pseudoglandular and early canalicular phases of lung develop-
ment (ref. 21 and Figure 1). However, maturation of secretory cells 
occurs over a protracted time frame that spans the late embryonic 
and postnatal periods. Maturation of secretory cells involves the 
acquisition of the cellular machinery necessary for metabolism of 
endogenous or xenobiotic compounds and for secretion of various 
constituents into the airway lining fluid (20, 22, 23). Basal cells 
appear in proximal conducting airways during postnatal matu-
ration of the epithelium. Expression of the transcription factor 
TRP63 defines the developmental progenitor cell pool that yields 
the basal cell population and is thought to be required for for-
mation of the pseudostratified airway, as p63-null mice lack basal 
cells and have a columnar ciliated tracheobronchial epithelium 
(24). Finally, maturation of the epithelium lining respiratory air-
ways, which yields alveolar epithelial type 1 and type 2 pneumo-
cytes, occurs during the late prenatal and early postnatal periods, 
in what is referred to as the “alveolar” phase of lung development 
(refs. 9, 25, and Figure 1). During this period, septation of primi-
tive alveoli and continuing expansion of the microcapillary net-
Figure 2
Regional differences in the cellular composition of the lung epithelium. Within the mouse lung, basal cells are restricted to the tracheobronchial 
epithelium, which is also p pulat d with secretory, ciliated, and euroendocrin  cells to form a pseudostratified epithelium. Beyond the most 
proximal bronchi, the airway of the mouse is composed of a simple columnar epithelium that consists of secretory, ciliated, and neuroendocrine 
cells. In human lungs basal cells are present in diminishing numbers all the way to the level of terminal bronchiole. Respiratory bronchioles are 
lined by a poorly ch racterized cuboid l epithe ium that lead  to the alveolar compartment lined with ATI and ATII cells. Putative progenitor cells 
have been identified using in vivo lineage-tracing experiments (Clara and basal cells) or proposed based on their capacity to proliferate and differ-
entiate in culture (Clara, basal, and ATII cells). The epithelium of the mouse trachea and proximal bronchi is maintained by airway basal cells (39, 
78). Within the bronchiolar region, a population of Clara cell secretory protein–expressing (CCSP-expressing) cells localized the neuroepithelial 
body in the proximal bronchiole and a population of naphthalene-resistant CCSP-expressing cells from the distal bronchiole of the mouse serve 
to regenerate their respective regional epithelia following cell-specific injury (66, 67). BASCs, at the bronchioalveolar duct junction, have been 
suggested to serve as progenitors with the capacity to renew both the bronchiolar and alveolar epithelium (68). Finally, it has been long believed 
that ATII cells serve as the progenitors that maintain the alveolar epithelium (73).
Downloaded on January 14, 2014.   The Journal of Clinical Investigation.   More information at  www.jci.org/articles/view/60519
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Figure 1.6. Regeneration and repair in the proximal airway epithelium. 
Multiple signaling pathways and complex developmental and regenerative relationships 
characterize the network of cells that comprise the airway epithelium. For example, in the 
trachea, interactions mediated primarily via Notch signaling drive the differentiation of 
secretory and basal cells to goblet and ciliated progenitors. Adapted from Kotton & 
Morrisey, 201456. 
 
The Airway Epithelium: Basal cells 
As with many other epithelial organs, highly-proliferative airway basal cells form 
a layer adjacent to the basement membrane of the pseudostratified epithelium of the 
proximal lung and trachea57. These cells are characterized primarily by the expression of 
the transcription factor p63, the function of which is required for their normal 
development58, and several cytokeratin proteins, including Krt14 and Krt558,59. The most 
important described function of these cells is as a stem cell population: tracing of the 
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studies attempting to identify adult stem or 
progenitor candidates in the lung have used 
injury and disease models primarily in rodents. Early studies of 
human and animal lung morphology defined subsets of lung epithe-
lia with proliferative capacity, including basal, secretory or club cells 
(formerly known as Clara cells) of the proximal ai way, a d AEC2s 
of the alveolus. All of these lineages have the capacity to enter the 
cell cycle in response to lung injury23,32–39. More recent techniques, 
including cell-lineage tracing, have suggested that most types of lung 
epithelial cells, except for airway ciliated cells, can proliferate and 
expand after injury to promote repair40–44. Importantly, identifying 
these cell populations provides key information about how to harness 
the endogenous abilities of the lung to regenerate.
Tracheal and proximal bronchial stem cell candidates. The trache  
and main stem bronchi (upper airways) of both humans and mice are 
lined with a pseudostratified epithelium composed of basal and luminal 
cells (Fig. 3). Luminal airway cells include secretory (club), ciliated 
and neuroendocrine cells. In the lungs of humans, as well as other 
mammals, this region of the airway also contains goblet cells, which are 
marked by expression of the transcription factor SPDEF and mucin-5ac 
(Muc5ac). Cell lineage–tracing studies in mice have shown that gob-
let cells, which arise in mice only after injury or in disease states, are 
derived from secretoglobin family 1a member 1–expressing (Scgb1a1+) 
secretory cells and not ciliated epithelial cells in the postnatal lung 
after injury45. Studies grafting basal and luminal cell populations into 
tracheas denuded of epithelium in mice followed by implantation of 
the reseeded tracheal xenografts into immunodeficient mice suggest 
that either basal or luminal cells can regenerate the tracheal epithe-
lium40,46,47. However, other studies suggest that only luminal48 or basal 
cells49 can restore all the tracheal epithelial subtypes.
Investigators have found subsets of basal cells in mice and humans 
that have extensive proliferative potential, self-renewal capacity and 
the ability to differentiate into basal, secretory and ciliated lung epi-
thelial cells in vivo50,51. Modern flow cytometry allows the cells to be 
sorted to purity and has enabled the cataloging of multiple gene and 
protein markers selectively expressed in these basal cells, including the 
basal cell–restricted transcription factor Trp63, the keratins Krt5 and 
Krt14 and the cell-surface markers Pdpn, NGFR and GS1 lectin B4. 
The global transcriptome of these cells has also been examined by 
microarray analysis50,52, and these studies have also highlighted 
the heterogeneity and diversity within the basal cell lineage51–55. 
Importantly, mouse basal cells can expand almost indefinitely in 
culture while retaining multipotent differentiation capacity, similar 
to classically studied stem cells of the skin50,55. This body of work, 
along with the prevailing view that basal cells have no other known 
function in the lung, supports the concept that basal cells can func-
tion as tissue-specific stem cells of the conducting airway epithelium. 
However, there is still much that is not known about basal cell self-
renewal and different atio  and w ether it nv lves asymmetric cell 
division as do other stem cells. The use of clonal multicolor cell 
lineage–tracing experiments should help to better define basal cell 
heterogeneity. The molecular mechanisms for basal cell self-renewal 
and differentiation are poorly understood, but recent evidence points 
to an important role for Notch signaling in promoting secretory 
cell fate over ciliated epithelial cell fate50,56 (Fig. 3). Importantly, 
determining whether the differentiation repertoire of basal cells of 
the airways includes the potential to reconstitute injured alveolar 
epit lial cells, as has b en suggested55, will require confirmatory 
lineage-tracing studies.
Distal airway stem cell candidates. The more distal bronchiolar 
region of mouse lungs are lined with a monolayered epithelium con-
sisting of secretory, ciliated and neuroendocrine epithelial lineages 
(Fig. 4). Krt5+Trp63+ basal cells also line this region of the airway 
tract in humans, but their presence has not been well documented in 
the rodent lung. Ciliated epithelium is marked by expression of the 
transcription factor Foxj1 and the cytoskeletal protein Tubb4, and 
the secretory epithelium in this region is marked by expression of the 
secretoglobins Scgb1a1 and Scgb3a2 (ref. 57). Neuroendocrine cells 
are often clustered in neuroendocrine bodies (NEBs) and are marked 
by expression of ubiquitin carboxyl terminal esterase-L1 (UCHL1; 
also known as Pgp9.5), calcitonin gene–related peptide (CGRP) and 
the transcription factor Ascl1.
The bronchiolar epithelium is quiescent until injured. Using 
naphthalene-induced secretory epithelial cell depletion, several 
reports have shown that a subset of secretory cells expressing Scgb1a1 
but not cytochrome p450 (Cyp2f2) is spared from naphthalene toxicity 
and functions as a facultative progenitor, expanding rapidly to regen-
erate the damaged airways by forming both secretory and ciliated 
cell progeny58–60. Cell lineage–tracing experiments have shown 
that Scgb1a1+Cyp2f2− cells can self-renew and differentiate into 
Tubb4+Foxj1+ ciliated epithelium during normal homeostatic turn-
over as well as after naphthalene-induced injury61. This has prompted 
some to name them variant club cells. Cell proliferation has an 
important role in this injury response, but it remains unclear whether 
Scgb1a1+Cyp2f2− cells go through a process of dedifferentiation to re-
enter the cell cycle and then differentiate again after expansion. Their 
region-specific location adjacent to NEBs62 of the airways or at the 
bronchoalveolar duct junctions (BADJs)63 are compelling evidence of 
Secretory (club) cell Ciliated cellGoblet cell
Basal cell
D
eb
bi
e 
M
ai
ze
ls
/
N
at
ur
e 
P
ub
lis
hi
ng
 G
ro
up
HDAC1/2-mediated
proliferation
Neuroendocrine cell
Epithelium of
trachea and
main bronchi
Lumen of trachea and bronchi
Notch
Notch
Trp63+
Krt5+
Krt14+
Pdpn+
NGFR+
GSI-B4+
Spdef+
Muc5ac+
Figure 3 Stem cell and differentiated epithelial 
lineages in the trachea and main stem bronchi 
of the lung. The trachea and most proximal 
airways of the rodent and human lung are lined 
with multiple epithelial lineages. Basal cells 
are located in this region and can generate 
secretory and ciliated cell lineages. Cell 
signaling pathways such as Notch are crucial for 
differentiation of basal cells and also suppress 
the ciliated epithelial–cell fate. HDAC1 and 
HDAC2 (HDAC1/2) are essential for secretory 
epithelial regeneration. Red arrows indicate 
cells that have been shown by lineage-tracing 
techniques to generate the indicated lineages 
after injury or during homeostasis. 
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Krt5+ population in the lungs of mice revealed that basal cells contribute to the luminal 
cell population (e.g. ciliated and secretory cells) throughout normal lung homeostasis as 
well as in repair after injury60. This contribution is caused by the differentiation and 
migration of the basal layer into the luminal layer of the epithelium and is mediated 
primarily by Notch signaling. Notch is both required for differentiation of basal cells to 
luminal cells and controls the proportions of secretory (high-Notch) versus ciliated (low-
Notch) progeny61,62. Relatedly, Notch also helps mediate the cellular composition of the 
epithelium; signaling from basal cells to secretory cells via Notch2 inhibits secretory 
differentiation to ciliated cells under homeostatic conditions and is consequently required 
for maintenance of the normal epithelial composition63.  
Due to their proliferative potential and differentiation capacity, tracheal basal 
cells from both mice and humans are commonly employed in in vitro models, where 
these progenitors differentiate to a polarized, multiciliated epithelium in response to air-
liquid interface or in “tracheosphere” culture60,64,65. 
The Airway Epithelium: Secretory (club) cells 
Lung secretory cells are marked by the expression of club cell secretory protein 
(Cc10/Ccsp/Scgb1a1) and are an abundant and heterogeneous secretory lineage, localized 
primarily to the distal airways, that provides critical protective functions to the lung by 
participating in immune modulation, oxidative stress reduction, and xenobiotic 
metabolism41,55,66. Structurally, lung secretory cells are characterized by numerous apical 
granules containing secretory products, including Scgb1a167,68. In addition to this protein, 
the expression of diverse secretoglobin family members, including Scgb3a1 and Scgb3a2 
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may be expressed in heterogeneous populations of secretory cells and are important to the 
function of these cells in immune homeostasis and mediation of oxidant-induced 
stress69,70. 
In addition to their diverse functional roles, club cells are also capable of 
differentiation to other proximal cell types, are the major known progenitor for ciliated 
and goblet cells, and can reconstitute the airway epithelium after injury60,71. Lineage 
tracing of these cells reveals low turnover in the airways during homeostatic conditions, 
however, these cells contribute significantly to repair in the context of substantial airway 
damage71,72. Similarly, depletion of the club cell lineage results in attenuated repair of the 
lung and a consequent fibrotic phenotype73,74. Adding to their potential regenerative 
capacity, secretory cells are also capable of “reversion” to basal cells under certain 
conditions75. 
While their differentiation potential has mostly been explored in the context of 
epithelial repair, secretory cells are also thought to be the major source of goblet cells in 
the context of mucus metaplasia and have been shown to upregulate mucin expression in 
response to diverse immune signals, including antigen challenge, allergen exposure, and 
IL-13 stimulation76-78. While signaling via Notch2 is required for the development and 
maintenance of the secretory cell lineage and mediates in particular the decision between 
secretory and ciliated fate during development79,80, it has additionally been shown that 
loss of Notch signaling in postnatal club cells leads to mucus metaplasia, suggesting a 
key role for this pathway in mediating the relationship between secretory and goblet 
cells81. 
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Although there are few markers describing subsets of secretory lineages in the 
lung, the heterogeneity of this population has been well-characterized. The main 
functional subset of secretory cells are variant club cells, which are localized adjacent to 
neuroepithelial bodies, resistant to naphthalene ablation due to reduced cytochrome p450 
expression, and are able to reconstitute the airway epithelium after injury82,83. In addition 
to Scgb1a1, these cells are primarily marked by the expression of Upk3a and other 
secretory genes, including Scgb3a269,84. The variant club cell lineage is also expanded in 
the context of beta-catenin activation, which likely acts to prevent differentiation and 
consequently results in increased proliferation and expansion of this facultative 
progenitor population82. 
Another putative club cell subpopulation has been identified that coexpresses 
Sftpc along with Scgb1a1. These cells (termed “bronchioalveolar stem cells,” or BASCs), 
were initially isolated and shown to differentiate in vitro to alveolar as well as secretory 
and ciliated lineages and hypothesized to represent a putative “lung stem cell” 
population85. Additional evidence, however, has suggested that BASCs do not have 
regenerative potential beyond that of the club cell population as a whole71. Other work 
from Rock et al. has shown that both influenza and bleomycin injuries can induce the 
differentiation of Scgb1a1-lineage traced cells to type II and type I cells, although this 
study does not address the relative contribution of Spc- club cells, Spc+ BASCs or 
Scgb1a1+ type II cells to this repair process86. 
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The Airway Epithelium: Goblet cells 
The primary function of lung goblet cells is to secrete mucus, a sticky substance 
made up primarily of a family of glycoproteins known as mucins that help to protect the 
lung by trapping inhaled pathogens55,87. Overproduction of mucus (goblet cell 
hyperplasia and/or mucus metaplasia) is a hallmark of multiple lung diseases, including 
COPD, cystic fibrosis, allergic lung disease and asthma87,88. Differentiation of goblet 
cells from club cells is regulated by several transcription factors, including Foxa389 and 
the Ets-like transcription factor Spdef, the latter of which promotes mucin gene 
expression and downregulates expression of other key lung genes, including Nkx2-176,90. 
In addition to these transcription factors, several models have identified Notch as a key 
regulator of goblet cell development. Specifically, overactive Notch signaling early in 
development promotes the emergence of goblet cells at the expense of ciliated cells and 
Notch inhibition can prevent mucus metaplasia in in vivo models91. However, Notch 
deletion promotes the transdifferentiation of club cells to goblet cells in postnatal mice81, 
suggesting this pathway may play distinct regulatory roles at different developmental 
stages.  
The Airway Epithelium: Ciliated cells 
Lung ciliated cells are the key functional cell type of the mucociliary escalator; 
these polarized cells contain apical, motile cilia that beat in a synchronized motion to 
clear mucus and debris from the airway55. These motile cilia are comprised of 
microtubules organized in a 9+2 ultrastructure and attached to inner and outer dynein 
arms that serve as molecular motors to drive ciliary beat92,93. The initiation of ciliogenesis 
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is mediated in part by the transcription factor Foxj1, the major regulator of ciliated cell 
development93. Not surprisingly, genetic defects in the assembly of the cilia complex 
result in ciliopathies, such as primary ciliary dyskenisia (PCD), diseases that are 
characterized by a lack of functional cilia and consequent persistent lung disease94,95. 
Unlike secretory cells, ciliated cells are a terminally differentiated population and there is 
no mechanistic evidence that ciliated cells contribute to airway regeneration or mucus 
metaplasia96,97. As with the other airway cell types, the developmental differentiation of 
ciliated cells is primarily mediated by Notch signaling. In particular, inhibition or loss of 
Notch2-dependent signaling during development leads to increased ciliated cell 
differentiation and depletion of the secretory lineage79,80,98. 
 
I.3. Pluripotent Stem Cells 
Basics of Pluripotent Stem Cells 
Murine embryonic stem cells (mESCs) are derived from the inner cell mass 
(ICM) of the pre-implantation mouse blastocyst99,100 and retain a number of key 
characteristics of this developmental stage that make them a useful tool for studying cell 
fate decisions in vitro. Like the ICM from which they are derived, mESCs are pluripotent 
and thus able to contribute to all three germ layers of the embryo but not to 
extraembryonic tissues101, a property that was initially demonstrated by both teratoma 
formation assays100 and the generation of viable chimeric mice by blastocyst injection of 
mESCs102. These chimeric mice contain contributions from mESCs in all three germ 
layers, including in germ cells, which also supports the conclusion that these cells are 
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able to maintain a normal diploid karyotype across passages102. Importantly, mESCs also 
have the innate capacity to indefinitely self-renew while maintaining a so-called “naïve” 
pluripotent state akin to that of the pre-implantation blastocyst. It has been demonstrated, 
however, that maintenance of this phenotype in culture requires the addition of 
exogenous factors that inhibit differentiation signals and consequently promote intrinsic 
ESC self renewal103. While initial approaches for ESC maintenance relied on culture with 
mouse embryonic fibroblast (MEF) feeder cells to provide trophic support for ESC self-
renewal, it was found that this feeder layer could be replaced by media containing 
leukemia inhibitory factor (LIF) to promote self-renewal104 via STAT3-mediated 
inhibition of differentiation105,106. Over time, defined media for use in culturing ESCs has 
been further refined; in particular, Ying et al. demonstrated that other factors that prevent 
ESC differentiation, such as the Erk inhibitor PD184352, can promote self-renewal and 
replace LIF in ESC maintenance culture103,107. From this result, “2i” media was 
developed, combining this differentiation inhibitor along with the GSK3β inhibitor 
CHIR99021, which was similarly shown to promote cell growth and cell survival in 
mESCs103. 
Human Embryonic Stem Cells 
Much like mouse ESCs, human ESCs (hESCs) were first isolated from the 
developing blastocyst108,109 and similarly are pluripotent and able to self-renew 
indefinitely in culture, although the culture conditions required to maintain mouse versus 
human ESCs are distinct110. Relatedly, there is significant evidence that mESCs and 
hESCs are developmentally different; hESCs are thought to be “primed” towards specific 
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differentiated lineages, and consequently exist at a developmental state and molecular 
phenotype more reminiscent of mouse cells derived from the post-implantation epiblast, 
known as epiblast stem cells (EpiSCs) than “naïve” pre-implantation mESCs110-112. In 
practice, this means that even pluripotent hESCs have variable in vitro differentiation 
potential across lines. Consequently, recent work has sought to develop culture 
conditions to maintain hESCs in a more “naïve” state, but this has not yet been 
demonstrated convincingly110,113. 
 
Figure 1.7. Source of pluripotent cells from the mouse embryo. 
mESCs are derived from the E3.5 blastocyst and are phenotypically similar to the E4-6 
pre-implantation epiblast. In contrast, hESCs are more similar to mouse EpiSCs, which 
are derived from the E5.5 epiblast, as illustrated here. From Davidson et al., 2015113. 
 
Induced Pluripotent Stem Cells 
While the potential applications of pluripotent stem cells are evident from their 
ability to differentiate to any tissue type of the body and consequently illuminate 
important biology of cell fate and development, their potential was augmented 
significantly by the discovery that overexpression of four key transcription factors can 
X-inactivation, energy generation through glycolysis, poor cloning
efficiency as single cells, lineage priming and little or no ability to
participate in chimera formation (Hackett and Surani, 2014). In
addition to the characteristic changes in expression of a specific
subset of genes that marks the transition between the naïve state and
the post-implantation epiblast-like EpiSC (Table 1), the expression
of all pluripotency-associated genes is more uniform in naïve cells
in vivo or in vitro compared with EpiSCs. Low variability of gene
expression nd the absence of lineage priming suggest that in vitro,
the naïve cell might represent a stable, deep attractor state (a stable
state toward which a system will evolve). However, the naïve state
converts within hours in culture (if conditions are altered) or in the
embryo, to intermediates that show wider variability in pluripotent
gene expression as well lineage priming. Hence, the naïve attractor
state is subject to rapid and facile remodelling in vivo (Kalkan and
Smith, 2014).
Recent work has refined our understanding of the developmental
status of stem cell lines corresponding to the post-implantation
epiblast. Careful comparison between gene expression in mEpiSCs
derived at different stages of post-implantation development and the
mouse epiblast from E5.5 to E8.5 shows that mEpiSCs are most
similar to the ectoderm of the anterior primitive streak, a relatively
late stage of development (Kojima et al., 2014). By modifying the
culture conditions for mEpiSCs, Wu et al. were able to derive
mEpiSCs that were more similar to l te primitive streak-stage
epiblasts (Wu et al., 2015). Both of these studies indicate that
mEpiSCs are poised at a fairly late stage of epiblast development.
The naïve state: similarities and differences in vivo and in vitro
As noted above, the molecular and cellular properties of naïve PSCs
reflect the properties of the epiblast (Fig. 1). Prior to epiblast
formation, the constituent cells of the ICM are not yet committed to
the pluripotent or primitive endoderm lineages (an extra-embryonic
tissue that is the precursor of the yolk sac). Thus, prior to epiblast
segregation, levels of the pluripotency gene Nanog in the ICM are
bimodal, with low levels of expression associated with high levels
of expression of the primitive endoderm gene Gata4. After the
epiblast forms, Nanog levels are high within the pluripotent
compartment and low or undetectable in the primitive endoderm,
and gene expression in the epiblast cells reflects a uniform
pluripotent state (Boroviak et al., 2014; Guo et al., 2010). The
absence of co-expression of lineage and pluripotency markers
represents a transient state in mouse development, because very
soon after implantation, the post-implantation epiblast begins to
express germ layer lineage-specific markers in preparation for
gastrulation.
In vitro, it has repeatedly been observed that mESCs are
heterogeneous for expression of Nanog (Chambers et al., 2007).
Although mPSCs can flux between Nanog+ and Nanog– states
in vitro, this is not reflected in the embryo in vivo, where, once
epiblast cells become specified, they no longer move backwards in
developmental time to give rise to primitive endoderm (Xenopoulos
et al., 2015). mPSCs grown under conditions that support naïve
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Fig. 1. The pluripotent lineage in themouse embryo.Up to the eight-cell stage, blastomeres are totipotent. At embryonic day (E) 3.5, the inner cell mass (ICM)
cells express both pluripotency and extra-embryonic endoderm genes. At E4.5, the epiblast and primitive endoderm lineages segregate; at this stage, the epiblast
represents the naïve state of pluripotency. The E4.5 epiblast is the cell of origin of mESC; although mESC can be derived from earlier embryonic stages, the cells
of earlier embryos mature in vitro to the epiblast stage in ESC generation. In mouse, shortly after E4.5, the embryo implants in the womb. EpiLCs, which are
derived from mouse ESCs and are said to be in a state of ‘formative’ pluripotency, are thought to be equivalent to E5.5 epiblast cells. EpiSCs, which are in a
‘primed’ pluripotent state, are most similar to late E6.5 epiblast, although they may be derived from E3.5 up to E6.5. In the human (data not shown), the blastocyst
forms on day 5 and the epiblast emerges on day 6-7, when the embryo consists of 150-300 cells. For more comparison of human and mouse peri-implantation
development see Pera and Trounson (2004). The pluripotent lineage is shown in green.
Table 1. Key characteristics of the naïve and primed pluripotent stem
cell states
Naïve state PSCs Primed state PSCs
Corresponding
in vivo tissue:
Early epiblast (pre-
implantation)
Epiblast (peri-/post-
implantation)
Colony
appearance:
Compact dome Flattened
Genes
expressed:
Oct4, Nanog, Sox2,
Klf2, Klf4, Klf5,
Zpf42, Esrrb,
Dppa3, Tfcp2l1,
Fgf4, Tbx3
Oct4, Nanog, Sox2,
Dmnt3b, Fgf5,
Pou3f1, Meis1,
Otx2, Sox11, Gdf3
Oct4 enhancer
usage:
Distal Proximal
Global DNA
methylation:
Hypomethylated Hypermethylated
Female X
chromosome
status:
Two active X One inactivated X
Clonogenicity: High Low
Gene targeting
feasibility:
Amenable to gene
targeting
Low targeting
efficiency
Chimeric
contribution in
rodents:
High Low
Level of HERVH*
expression:
High Low
Growth factor
dependence:
LIF Activin, FGF2
*HERVH is a primate-specific endogenous retrovirus.
Features are based primarily on data from the mouse (Hackett and Surani,
2014), except for HERVH expression (Wang et al., 2014).
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reprogram differentiated, somatic cells back to a pluripotent state114-117. These “induced” 
pluripotent stem cells (iPSCs) share most features of ESCs, including indefinite self 
renewal and the ability to differentiate to any tissue of the body. Unlike ESCs, however, 
the ability to derive these cells readily from any person suggests the potential of directed 
differentiation of iPSCs  (discussed further in Chapter I.4, below) as an inexhaustible 
source of patient-derived cells for disease modeling, cell-based therapy without risk of 
immune compromise, drug screening, and precision medicine (Figure 1.8). 
iPSCs: Biology of Reprogramming 
The process of reprogramming somatic cells to iPSCs is initiated by the 
overexpression of the core pluripotency transcription factors Oct4, Klf4, Sox2, and c-
Myc (OKSM). The initial stages of reprogramming manifest as “dedifferentiation” 
characterized by increased proliferation and downregulation of lineage-specific 
genes118,119. During this early stage of reprogramming, cells are dependent on the 
continued expression of OKSM119.  
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Figure 1.8. Potential therapeutic applications of iPSCs. 
There are many potential applications of patient-derived iPSCs reliant on differentiation 
to cell types of interest. In particular, the development of in vitro disease models for drug 
screening and the generation of healthy iPSCs by gene correction as a source of immune-
matched, transplantable cells are two potential approaches with clinical promise. From 
Robinton & Daley 2012120. 
 
 
 Full conversion of cells to pluripotency relies on changes to epigenetic markers, 
including DNA and histone methylation, and is consequently both inefficient and time-
consuming121. In particular, the establishment of a bivalent chromatin state on tissue-
specific genes122, X-reactivation in female cells123, retroviral silencing124,125, and removal 
of somatic epigenetic marks123 are hallmarks of “stable pluripotency”121. After this 
Given the number of drugs that have notoriously been withdrawn from 
th  market becaus  of their tendency to induc  arrhythmias, it is highly 
likely that the current inadequate approach s for assessing cardiotoxic-
ity will be complemented by iPS-cell-based assessments of drug effects.
A study from our laboratory explored dyskeratosis congenita, a dis-
order of telomere maintenance, and provided an unanticipated insight 
into the basic biology of telomerase that has therapeutic implications73. 
In its most severe form, dyskeratosis congenita is caused by a mutation 
in the dyskerin gene (DKC1), which is X linked, leading to shortened tel-
omeres and premature senescence in cells and ultimately manifesting as 
the degeneration of multiple tissues. Because the reprogramming of cells 
to an induced pluripotent state is accompanied by the induction of the 
gene encoding telomerase reverse transcriptase (TERT), we investigated 
whether the telomerase defect would limit the derivation and mainte-
nance of iPS cells from individuals with dyskeratosis congenita. Although 
the efficiency of iPS-cell derivation was poor, we were able to successfully 
reprogram patient fibroblasts. Surprisingly, whereas the mean telomere 
length immediately afte  reprog amming was shor er than that of the 
parental fibroblast population, continued passage of some iPS cell lines 
led to telomere elongation over time. This process was accompanied by 
upregulation of the expression of TERC, which encodes the RNA subunit 
of telomerase.
Further analysis established that TERT and TERC, as well as DKC1, 
were expressed at higher levels in dyskeratosis-congenita-derived iPS cells 
than in the parental fibroblasts73. We determined that the genes encoding 
these components of the telomerase pathway — including a cis element 
in the 3ʹ region of the TERC locus that is essential for a transcriptionally 
active chromatin structure — were direct binding targets of the pluri-
potency-associated transcription factors. Further analysis indicated that 
transcriptional silencing owing to a 3ʹ deletion in the TERC locus leads to 
the autosomal dominant form of dyskeratosis congenita by diminishing 
TERC transcription. Although telomere length is restored in dyskeratosis-
congenita-derived iPS cells, differentiation into somatic cells is accompa-
nied by a return to pathogenesis with low TERC expression and a decay in 
telomere length. This finding showed that TERC RNA levels are dynami-
cally regulated and that the pluripotent state of the cells is reversible, sug-
gesting that drugs that elevate or stabilize TERC expression might rescue 
defective telomerase activity and provide a therapeutic benefit. Although 
we set out to understand the pathogenesis of dyskeratosis congenita with 
this study, we showed that a high expression level of multiple telomerase 
components was characteristic of the pluripotent state more generally, 
illustrating how iPS cells can reveal fundamental aspects of cell biology.
An independent study of the reprogramming of cells from patients with 
dyskeratosis congenita confirmed the general transcriptional upregula-
tion of multiple telomerase components and the maintenance of telomere 
lengths in clones74; however, in this study, no clones with elongated telom-
eres were identified. The different outcomes of these studies highlight the 
limitations of iPS-cell-based disease models that are imposed by clonal 
variation as a result of the inherent technical infidelity of reprogram-
ming75. This point also introduces an additional important consideration. 
Before a given iPS-cell disease model can be claimed to be truly represent-
ative of the disease, how many patients must be involved, and how many 
iPS cell lines must be derived from each patient? Although the answers to 
these questions are unclear, it is crucial to keep these issues in mind when 
generating disease models and making claims based on these models.
Although iPS cells are an invaluable tool for modelling diseases in vitro, 
the goal of developing patient-specific stem cells has also been motivated 
by the prospect of generating a ready supply of immune-compatible cells 
and tissues for autologous transplantation. At present, the clinical trans-
lation of iPS-cell-based cell therapies seems more futuristic than the in 
vitro use of iPS cells for research and drug development, but two ground-
breaking studies have provided the proof of principle in mouse models 
that the dream might one day be realized. Hanna, Jaenisch and colleagues 
used homologous recombination to repair the genetic defect in iPS cells 
derived from a humanized mouse model of sickle-cell anaemia76. Directed 
differentiation of the repaired iPS cells into haematopoietic progenitors 
followed by transplantation of these cells into the affected mice led to 
the rescue of the disease phenotype. The gene-corrected iPS-cell-derived 
haematopoietic progenitors showed stable engraftment and correction of 
the disease phenotype.
In another landmark study from Jaenisch’s research group, Wernig 
and colleagues derived dopaminergic neurons from iPS cells that, when 
implanted into the brain, became functionally integrated and improved 
the condition of a rat model of Parkinson’s disease77. The successful 
implantation and functional recovery in this model is evidence of the 
therapeutic value of pluripotent stem cells for cell-replacement therapy 
in the brain — one of the most promising areas for the future of iPS-
cell applications.
Figure 2 | Medical applications of iPS cells. 
Reprogramming technology and iPS cells have 
the potential to be used to model and treat 
human disease. In this example, the patient has 
a neurodegenerative disorder. Patient-specific 
iPS cells — in this case derived by ectopic 
co-expression of transcription factors in cells 
isolated from a skin biopsy — can be used in one 
of two pathways. In cases in which the disease-
causing mutation is known (for example, familial 
Parkinson’s disease), gene targeting could be 
used to repair the DNA sequence (right). The 
gene-corrected patient-specific iPS cells would 
then undergo directed differentiation into the 
affected neuronal subtype (for example, midbrain 
dopaminergic neurons) and be transplanted into 
the patient’s brain (to engraft the nigrostriatal 
axis). Alternatively, directed differentiation of 
the patient-specific iPS cells into the affected 
neuronal subtype (left) will allow the patient’s 
disease to be modelled in vitro, and potential drugs 
can be screened, aiding in the discovery of novel 
therapeutic compounds.
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transition to stable pluripotency has occurred, cells are no longer reliant on ongoing 
exogenous OKSM expression121. 
While OKSM overexpression requires the introduction of exogenous DNA into 
cells, multiple methods for overexpressing OKSM in differentiated cells for the purposes 
of reprogramming while maintaining the ability to downregulate or remove these 
exogenous factors after the establishment of stable pluripotency have now been 
described. One efficient method uses a lentiviral vector that integrates into the genomic 
DNA a single cassette overexpressing OKSM and surrounded by specific sequences (e.g. 
Lox), such that this “stem cell cassette” (STEMCCA) can be excised by a site-specific 
recombinase (e.g. Cre) after reprogramming is complete (see Chapter III for more 
details)126-128. Importantly but unsurprisingly, this excision step enhances the 
differentiation potential of these reprogrammed cells127. 
 
I.4. Directed Differentiation 
Overview of Directed Differentiation 
A major application of pluripotent stem cells (PSCs) is the directed differentiation 
of these cells to diverse cell types of interest. Much like normal development, this 
approach relies on a response to stage-specific, sequential developmental signals and the 
consequent sequential restriction of cell fate. For example, much like in normal 
development, lung progenitors derived from iPSCs arise via the primitive streak and 
definitive endoderm, then proceed via anterior foregut endoderm to an Nkx2-1+ lung 
fate129-131. In general, this approach is useful not only as a model with the capacity to 
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reveal cell fate decisions in high resolution and real time, but also for the generation of 
patient and tissue-specific cell types for disease modeling and drug screening.  
Directed Differentiation to Endodermal Lung Progenitors 
Methods have been generated to derive definitive endoderm from both mouse and 
human PSCs, mainly via the activation of Nodal signaling and consequent gastrulation 
and formation of the primitive streak via high-dose Activin A5. Additional studies using 
Bry and Foxa2 reporters have revealed that BMP, Wnt, and nodal signaling are required 
for and drive the formation of the primitive streak from PSCs132,133. However, continued 
activation of BMP and Wnt after establishment of the primitive streak result in generation 
of a more posterior identity, resulting in emergence of mesodermal fate at the expense of 
the endoderm133.  
  PSC-derived endoderm expresses early lineage markers (e.g. FoxA2), 
differentiates to multiple endodermal lineages after transplantation in the mouse kidney 
capsule5 and can be driven in vitro with further patterning to more differentiated 
endodermal lineages, such as hepatocytes134. These PSC-derived endodermal progenitors 
can also be patterned, much like the in vivo early endoderm, to subsets of foregut cells. 
Relevant to the goal of differentiating lung lineages is the ability to drive the expression 
of anterior foregut markers via the dual inhibition of BMP and TGFβ signaling130. When 
derived from either mouse or human PSCs, these anterior foregut cells are then able to 
respond to FGF2 and BMP signaling to differentiate to Nkx2-1+Pax8+ thyroid 
progenitors129,135 or to combinatorial Wnt, retinoic acid, and BMP signaling to 
differentiate to Nkx2-1+Pax8- lung progenitors (Figure 1.9)17,129,131. Recent work from 
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our group has characterized these NKX2-1+ lung progenitors in detail and demonstrated 
that they can differentiate to SFTPC+ type II pneumocytes in response to trophic 
stimulation by defined factors (e.g. CHIR99021, FGF10, KGF, steroids) or co-culture 
with mouse lung mesenchyme136. The specific protocols used in this project and the role 
of Wnt signaling in the differentiation of lung progenitors are shown in Figure 1.9 and 
further explored in later research chapters.  
Figure 1.9. Directed differentiation of lung progenitors from PSCs. 
Human PSCs can be differentiated to NKX2-1+ lung progenitors by stepwise generation 
of developmental intermediates. hPSCs are differentiated via primitive streak to 
definitive endoderm by activation of Nodal signaling using Activin A. Anterior foregut 
fate is then established by dual inhibition of BMP and TGFβ signaling by the small 
molecules Dorsomorphin and SB431542, respectively. Finally, activation of Wnt and 
BMP signaling in the presence of retinoic acid drives differentiation to NKX2-1+  lung 
epithelium. 
 
As directed differentiation tends to be inefficient and heterogeneous, the 
engineering of reporter cell lines allowing for live-cell sorting of populations of interest is 
critical to the study of cell fate decisions during directed differentiation. For example, our 
lab has previously published the use of reporter lines for assessing signaling pathways 
active in early endodermal lung lineage specification in mouse ESCs129.  These reporter 
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lines can be generated via a number of gene engineering approaches to introduce both a 
double-stranded break and repair template containing the reporter sequence to the cells of 
interest. The approaches used to generate reporter lines for this project will be discussed 
in further detail in later chapters. 
Clinical Applications of Directed Differentiation 
In addition to providing a high-resolution mechanism by which to study cell fate 
decisions, directed differentiation also has the potential to provide a platform for disease 
modeling and drug screening on an individual level, as well as an inexhaustible source of 
cells for cell-based therapy. While a lack of efficient protocols to differentiate mature cell 
types of interest have limited the current clinical applications of this technology, some 
clinical trials have been initiated for diseases affecting cell types where there exist robust 
directed differentiation protocols, including Parkinson’s disease, diabetes, myocardial 
infarction, and macular degeneration (reviewed in Trounson & DeWitt, 2016)137. The 
macular degeneration trials, for example, rely on the directed differentiation of retinal 
pigment epithelium from hPSCs, a goal that has been relatively straightforward to 
achieve relative to other lineages. Initial reports from Phase I/II clinical trials of hESC-
derived retinal pigment epithelium transplantation into patients with macular 
degeneration or Stargardt's macular dystrophy found few adverse events and improved 
visual acuity in many patients138,139. This represents the first clinical trial attesting to the 
safety and putative efficacy of any hPSC-derived treatment in human patients, paving the 
way for future studies in other organ systems and diseases. With these initial successes in 
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mind, the generation of improved protocols to generate mature, functional lung cell types 
from PSCs remains a critical goal in the applications of iPSC technology to lung diseases. 
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II. RATIONALE, HYPOTHESIS, AND SPECIFIC AIMS 
The overall goal of this dissertation project is to develop mouse and human 
pluripotent stem cell-based models to 1) study the molecular cues regulating the 
differentiation of proximal airway epithelium from pluripotent stem cells and 2) generate 
clinically relevant human airway progenitors from human iPSCs. Based on published 
genetic mouse models demonstrating Wnt activity in the developing mouse lung and our 
preliminary data, the focus of this project is the hypothesis that stage-specific inhibition 
of canonical Wnt signaling in PSC-derived Nkx2.1+ lung progenitors 
promotes proximal airway epithelial patterning and club cell differentiation.  
My progress towards these goals has been accomplished through three specific aims: 
 
AIM 1: Develop a novel model system to study club cell development and derive airway 
progenitors that can be sorted to purity. 
• Aim 1a: Identify new cell surface markers to track and purify mouse secretory 
cells using in vivo models and directed differentiation of mouse iPSCs. 
• Aim 1b: Engineer a novel dual knock-in club cell reporter mouse and 
accompanying mouse iPSC line for the tracking and purification of developing 
lung cells as they undergo differentiation from Nkx2.1+ precursors into CC10+ 
putative airway club cells and their progeny. 
• Aim 1c: Engineer a novel SCGB3A2 reporter hPSC line to track, purify, and 
characterize differentiating human secretory progenitors 
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AIM 2: Define important molecular mechanisms controlling club cell lineage 
specification and later differentiation in lung development. 
• Test the role of Wnt signaling in club cell development by agonizing and 
antagonizing this signaling pathway at defined stages during directed 
differentiation.  
 
AIM 3: Generate clinically relevant human airway progenitors from human iPSCs. 
• Derive purified proximal airway organoids from human iPSCs derived from 
normal volunteers or from patients with cystic fibrosis pre- and post-gene 
correction and test CFTR-dependent assays in these cells. 	
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III. IN VIVO AND IN VITRO MOUSE MODELS TO STUDY AIRWAY 
DEVELOPMENT  
NOTE: The characterization of Flk1 expression in the developing airway 
epithelium described in this chapter was performed in collaboration with Valerie Gouon-
Evans and Songyan Han, Mt. Sinai School of Medicine, New York, NY 	
III.1. Rationale 
Addressing many key questions in proximal lung development remains difficult 
using current models due to difficulty precisely manipulating multiple signaling pathways 
to study combinatorial and temporal aspects of developmental signaling and limited 
ability to access and characterize specific cell types during early stages of development. 
Due to these limitations, the use of reporter stem cell lines (e.g. Nkx2-1GFP; 
Cc10CreERT2; Rosa26-LSL-CreERTM) to study club cell development in vivo and  in vitro 
is critical to the advancement of the field of lung development and the biology of repair 
and regeneration. In particular, an in vitro iPSC-based system allows for easy access to 
sortable populations of club cells at early developmental stages that are difficult to study 
in vivo and creates a method by which developmental pathways can be easily 
manipulated at precise timepoints. 
Similarly, the identification of novel cell surface receptors in developing club 
cells is a critical step in expanding this approach of lineage purification to cell lines 
without an engineered cell type-specific reporter, which may be an important step 
towards building easily accessible and highly specific disease models from patient-
derived iPSC lines.  Here, we describe the identification of Flk1 (VEGFR2/KDR) in the 
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developing club cell lineage. Until recently, Flk1 was thought to be expressed exclusively 
in mesodermal lineages140. However, our previous work in liver development 
demonstrated that Flk1+ marks a conserved endodermal hepatic progenitor141. Following 
from this, we use a Flk1YFP lineage trace to identify a key window of Flk1 expression in 
the developing airway coincident with club cell differentiation. 
We further provide preliminary results that this cell surface receptor can be used 
to enrich for club cells derived from induced pluripotent stem cells (iPSCs) using our 
Nkx2-1/Scgb1a1 reporter mouse iPSC line. This finding thus facilitates the purification 
of club cells derived in vitro for applications of disease modeling or cell-based therapy. 	
III.2. Materials and Methods 
Generation of reporter mouse lines 
All mouse studies involving Nkx2-1GFP and Scgb1a1tdTomato lineage trace reporters 
were approved by the Institutional Animal Care and Use Committee of Boston University 
School of Medicine. We previously described the generation of Nkx2-1GFP mice129. 
Scgb1a1CreERT2 mice were obtained from Brigid L. M. Hogan, Duke University Medical 
Center, via Jackson Laboratories. Rosa26-LSL-tdTomato mice were obtained from 
Hongkui Zeng, Allen Institute for Brain Sciences, via Jackson Laboratories.  
 Mice used for Kdr lineage tracing studies (Kdr-Cre, Rosa26-EYFP) were 
generated as described previously141. These mice were used under approval of 
Institutional Animal Care and Use Committee of Mount Sinai School of Medicine. 
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Generation of murine iPSCs from tail tip fibroblasts 
Tail tip fibroblasts (TTFs) were isolated from adult mice and expanded in 
complete media containing DMEM, 10% FBS, L-glutamine and pen/strep (Gibco). After 
3 passages, TTFs were infected with a published lentiviral reprogramming vector128, 
murine Frt-flanked STEMCCA (encoding Oct4, Klf4, Sox2, and cMyc) and grown in 
mESC media supplemented with recombinant LIF (DMEM supplemented with 15% 
FBS, L-glut, LIF, and BME, as described previously129,135). Pluripotent colonies were 
individually picked and expanded on feeder fibroblasts to establish clonal iPSC lines. 
After several passages, iPSC clones were infected with a Flp-eGFP adenovirus (Vector 
Biolabs) and GFP+ infected cells were purified using flow cytometry. Lines were 
screened by PCR to confirm Flp excision of the STEMCCA virus. Excised lines were 
stained for pluripotency markers Oct4 and alkaline phosphatase using standard 
techniques. One established line, used for all directed differentiation experiments, was 
screened and found to be a karyotypically normal male line. Stable mouse iPSC lines 
were maintained on inactivated mouse embryonic fibroblasts in mESC media. 
Immunofluorescence on Lung Sections 
 Frozen sections of mouse lungs on glass slides were blocked with 4% normal 
donkey serum (Sigma) for 30 minutes at room temperature. Cells were incubated with 
primary antibodies against Flk1 (R&D Systems #AF644, 1:40), Nkx2-1 (Abcam 
#ab76013, 1:100), GFP (Aves #GFP-1020, 1:10000), Pgp9.5 (Dako #Z5116, 1:100), or 
FoxJ1 (eBiosciences #14-9965-80, 1:300) overnight at 4°C, washed, and incubated with 
secondary antibodies for 30-60 minutes at room temperature. All secondary antibodies 
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were conjugated to Alexa Fluor 488, Cy3, or Alexa Fluor 647 (Jackson Immunoresearch, 
1:500). After antibody staining, nuclei were stained with Hoescht dye (ThermoFisher, 
1:500) or DAPI (Sigma).  Slides were coverslipped using Prolong Diamond Anti-Fade 
Mounting Reagent (ThermoFisher) and imaged on a Nikon (Tokyo, Japan) deconvolution 
microscope or confocal microscope (Zeiss). When necessary, antigen retrieval was 
performed using a vegetable steamer  in Antigen Unmasking Solution (Vector Biolabs) 
prior to blocking step. 
Reverse Transcriptase Quantitative Real Time Polymerase Chain Reaction (RT-qPCR) 
Measurement of mRNA expression by reverse transcriptase quantitative real time 
PCR (RT-qPCR) was performed as previously described129. Briefly, RNA was extracted 
from cells using a QIAzol Lysis Reagent (Qiagen, Venlo, Netherlands) and 150 ng of 
RNA was transcribed to cDNA using reverse transcription reagents (Applied 
Biosystems). Real time PCR (qPCR) was performed using TaqMan Fast Universal PCR 
Master Mix (ThermoFisher) and TaqMan (Applied Biosystems) reagents. The cDNA was 
diluted 1:3 and 2 µL of cDNA was added to each 25 µL (for Applied Biosystems 
StepOne 96-well System) or 12.5 µL (for Applied Biosystems QuantStudio7 384-well 
system) qPCR reaction. Each sample was run in technical triplicates and cycle (Ct) values 
were averaged between triplicates for analysis. Relative gene expression, normalized to 
18S control, was calculated as fold change in 18S-normalized gene expression, compared 
to baseline, using the 2(-ΔΔCT) method. Baseline, defined as fold change=1, was set to 
undifferentiated iPSC levels, or if undetected, a cycle number of 40 was assigned to allow 
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fold change calculations. Adult lung control RNA was extracted from a normal lung 
biopsy sample. Primers were all TaqMan probes purchased from Applied Biosystems. 
Directed Differentiation of mESCs to Nkx2-1+ Lung Epithelium 
miPSCs were differentiated to lung epithelium as described previously129. Briefly, 
LIF was withdrawn for 60 hours to induce embryoid body (EB) formation. EBs were then 
treated with 100 ng/mL activin A (R&D Systems) for 60 hours. Anterior foregut 
endoderm was generated by dual BMP4 and TGFβ inhibition by SB431542 (10 µM) and 
rmNoggin (100 ng/mL, R&D Systems) for 24 hours. Lung specification was induced 
using rmWnt3a (100 ng/mL) and rhBMP4 (10 ng/mL) or rmWnt3a, rhBMP4, and 
rhFGF2 (250 ng/mL). Cells were sorted on day 14 for Nkx2-1GFP expression and replated 
for 2D culture outgrowth containing rhFGF2 (250 ng/mL) and rhFGF10 (100 ng/mL) as 
previously published135. 4-OH-tamoxifen (Sigma) was added to cultures to induce Cre-
mediated recombination at the Rosa26 locus and subsequent expression of tdTomato in 
Scgb1a1+ cells. 
 
III.3. Results 
Flk1 is a novel cell surface marker of Cc10+ club cells in the mouse airway 
It has previously been described that Flk1 marks an endodermal hepatic 
progenitor that arises early in in vivo liver development 141. We tested whether Flk1+ 
cells contribute to other endodermal organs by breeding a knock-in Flk1-Cre mouse 142 to 
a mouse carrying a constitutive YFP expressed from the Rosa26 locus preceded by a 
		
43 
floxed stop codon (Figure 3.1a-b). This system results in Cre-mediated excision of the 
stop codon and expression of YFP in Flk1+ cells, resulting in lineage labeling of this 
population 141 (hereafter Flk1YFPTrace).  
Figure 3.1. Flk1 lineage trace labels endodermal cells in the lung, but not the intestine or pancreas. 
(a) Schematic of Flk1YFPTrace reporter mouse generation and characterization experiments. 
(b) Schematic of modified alleles in Flk1YFPTrace reporter mice. (c) Representative 
immunofluorescence of P35 Flk1YFPTrace mice showing expression of Flk1 and YFP in the 
vasculature, but not the epithelium, of the pancreas and intestine and expression of YFP, 
but not Flk1, in the airway epithelium (arrow) of the lung.   
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 In the pancreas and intestine of lineage labeled mice, Flk1+ and Flk1YFPTrace+ cells 
were localized entirely to the mesodermal compartment, with no observed contribution 
from these cells to the endoderm (Figure 3.1c). In contrast, Flk1YFPTrace lineage labeling 
was detected throughout the endodermal airway epithelium. However, these Flk1YFPTrace+ 
cells did not express Flk1+ protein at this adult stage, suggesting that lung epithelial 
expression of this marker was restricted to an earlier developmental stage. 
To identify the precise developmental stage at which Flk1 is expressed in the lung 
epithelium, lungs of Flk1YFPTrace+ embryos at embryonic day (E) 13.5 (data not shown), 
E16.5 and E18.5 were sectioned and stained for Nkx2-1 to track lung epithelial identity 
(Figure 3.2a-d). We found that at E16.5, Flk1YFPTrace is expressed in the developing 
mesenchyme adjacent to the Nkx2-1+ epithelium, but not in the epithelium itself (Figure 
3.2b). By E18.5, however, we observed initial coexpression of Flk1YFPTrace and Nkx2-1 in 
many epithelial cells of the large airway, which increased in frequency until at least 
postnatal day 1 (Figure 3.2c-d). These results, as well as those from this same reporter 
system described below, were compared to control sections from Flk1YFP- mice and 
secondary only staining controls, which showed no observed fluoresence at the same 
image exposure. 
We next sought to look at higher resolution at developmental Flk1 protein 
expression in the lung between E16.5 and E18.5 by immunostaining of Flk1YFPTrace 
sections. Consistent with our lineage trace results, we observed sporadic initial 
expression of Flk1 protein in the epithelium at E16.5. By E18.5, the majority of the cells 
in the airway epithelium expressed this protein, and these levels persisted until postnatal 
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day 1 (Figure 3.2e). Together with our earlier data results, we concluded that Flk1 is 
upregulated in the airway epithelium around E16.5 and persists until at least the early 
postnatal stage before being downregulated in adult lungs (Figure 3.2f). 
  
Figure 3.2. Flk1 is expressed in the airway epithelium between E16.5 and E18.5. 
(a) Schematic of experiment examining developmental timing of airway Flk1 expression. 
(b-d) Representative immunofluorescence imaging showing no expression of Flk1YFPTrace 
in the developing airway epithelium (Nkx2-1+, red) at (c) E16.5 (continued on next page) 
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and colocalization of Flk1YFPTrace and Nkx2-1 in epithelial cells at (d) E18.5 and (e) P1 
with and without DNA (Hoescht, blue) counterstain. Scale=25 µm.  (e) Representative 
immunofluorescence staining at E16.5, E18.5, and P1 for Flk1 protein and Flk1YFPTrace. 
(f) Table summarizing stage-specific Flk1 expression in the developing airway 
epithelium. 	  
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Figure 3.3. Flk1 is expressed in airway club cells, but not neuroendocrine or ciliated cells. 
(a) Representative immunofluorescence of serial sections for Cc10 and Flk1 with and 
without DNA (Hoescht) counterstain. Arrows indicate Flk1+ parenchymal cells that are 
Cc10-.  Scale = 25 µm. (b) Representative immunofluorescence for (b) Foxj1 and (c) 
Pgp9.5 with Flk1YFPTrace with and without DNA (DAPI) counterstain. 
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The mature airway epithelium is comprised of multiple diverse cell types with defined 
functions, including club cells, ciliated cells, and neuroendocrine (NE) cells. As Flk1 
expression in the lung endoderm emerges during the canalicular stage of lung 
development, when many early lung progenitors acquire a more restricted, differentiated 
fate along with expression of mature lung markers 45,143.  
We next asked whether epithelial Flk1 is restricted to a particular airway cell type. 
To address this question, we costained for Cc10 (club cells) and Flk1. Although we were 
not able to evaluate coexpression using this model, the result showed expression of these 
markers in the same areas of the lung sections, suggesting that Flk1 labels airway club 
cells. (Figure 3.3a). Staining of Flk1YFPTrace lung sections for FoxJ1 (ciliated cells) and 
Pgp9.5 (NE cells) showed no colocalization with the Flk1 lineage marker, suggesting that 
within the distal airways, Flk1 expression is restricted to the club cell lineage during 
development (Figure 3.3b-c). However, we did not test for coexpression of this marker 
with other proximal lung epithelial lineages found outside of the distal airways, such as 
tracheal basal cells, and therefore cannot exclude the possibility that basal cells are also 
Flk1+ during development.  
Generation of a dual Nkx2-1;Cc10 reporter mouse and induced pluripotent stem cell line 
to track club cell specification 
Having identified Flk1 as a marker of developing club cells in vivo, we next 
wondered whether this surface receptor might identify club-like cells in in vitro directed 
differentiation of airway epithelium from pluripotent stem cells. Our laboratory has 
previously developed an in vitro protocol to derive lung epithelium from mouse ESCs, 
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which we have tracked using an Nkx2-1GFP knock-in reporter ESC line. These Nkx2-
1GFP+ progenitors can be sorted to purity, replated, and grown in maturation media for a 
week, at which point they begin to express multiple transcript markers of the mature lung, 
including Cc10129. 
To further characterize this putative club cell lineage, we generated a triple 
knock-in Nkx2.1GFP; Rosa26tdTomato; CC10CreERT2 (Nkx2.1GFP;CC10TomatoTr) reporter 
mouse by breeding previously reported individual knock-in mice71,129 (Figure 3.4a-b). To 
test the fidelity of this Nkx2.1GFP;CC10TomatoTr reporter system in vivo, we administered 
four doses of tamoxifen by intraperitoneal injection to induce lineage labeling in nearly 
100% of Cc10+ cells, (Figure 3.4c and previously reported71). While all lung epithelial 
cells expressed Nkx2-1GFP, only the airway epithelium and rare alveolar cells contained 
Cc10tdTomatoTr lineage labeled cells, consistent with the expected distribution of these 
markers in the normal mouse epithelium (Figure 3.4c, arrows). 
Next, tail tips were isolated from these triple knock-in mice, expanded in culture 
as dermal fibroblasts, and infected with an FRT-flanked STEMCCA lentiviral cassette 
encoding the four reprogramming transcription factors, Oct4, Klf4, Sox2, and c-Myc114 to 
generate putative iPSC clones that maintained stable morphology after serial passaging 
(Figure 3.4d). In order to generate iPSC lines free of any presence of exogenous 
reprogramming transgenes, the Frt-flanked STEMCCA cassette was excised via transient 
infection with an adeno-Flp-GFP fusion vector and confirmed excision by PCR screening 
(Figure 3.4d-e). Stably reprogrammed Nkx2.1GFP;CC10TomatoTr iPSCs expressed markers 
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of pluripotency, including alkaline phosphatase and Oct4 (Figure 3.4f) and were 
karyotypically normal (Figure 3.4g). 
Figure 3.4. Generation and characterization of Nkx2-1GFP; CC10tdTomatoTrace mouse iPSC line. 
(a) Schematic of single knock-in mice used to generate triple knock-in reporter. Triple 
knock-in adult mice were injected with tamoxifen 4x over 1 week to label lung club cells. 
(b) Schematic of knock-in alleles present in Nkx2-1GFP; CC10tdTomatoTrace mice. (c) Cross 
section of Nkx2-1GFP; CC10tdTomatoTrace mouse bronchiole coexpressing these reporters. 
Arrows indicate alveolar cells expressing CC10tdTomatoTrace. (d) Schematic of protocol for 
reprogramming mouse tail tip fibroblasts into iPSCs. (e) Schematic of STEMCCA 
reprogramming vector, integration, and Flp-mediated excision used in reprogramming. (f) 
Alkaline phosphatase staining and Oct4 immunofluorescence of reprogrammed, Cre-
excised Nkx2-1GFP; CC10tdTomatoTrace iPSC line. (g) Normal karyotype of Nkx2-1GFP; 
CC10tdTomatoTrace iPSC line. 
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To test the ability of this Nkx2.1GFP;CC10TomatoTr iPSC line to form club cells in 
vitro, we used our previously published stepwise, stage-specific approach to pattern cells 
via anterior foregut endoderm to Nkx2-1GFP+ lung and thyroid progenitors by day 15 of 
differentiation (Figure 3.5a-b). Cells were expanded post-specification in previously 
published media containing FGF2 and FGF10 to broadly ligate the FGF receptors and 
promote cell growth along with 4’OH-tamoxifen to induce Cre-mediated recombination 
of the Rosa26 locus in putative Cc10+ cells. After 12 days, cells were transitioned to 
“maturation media” containing dexamethasone, cyclic AMP, IBMX, and KGF (DCI+K). 
By Day 32, rare patches of cells coexpressed Nkx2-1GFP and Cc10tdTomatoTr. Nkx2-1GFP+ 
cells from Cc10tdTomatoTr  “high” and “low” regions were manually picked and analyzed 
for expression of club cell genes. tdTomatoHigh cells expressed Nkx2-1 at similar levels to 
tdTomatoLow cells and were enriched for expression of Cc10, Scgb3a2, and club cell 
marker Upk3a and were depleted for expression of Foxj1 (Figure 3.5c). Together with the 
in vivo characterization of this reporter, these results suggest that tdTomato labels a club 
cell-like population in in vitro directed differentiation. 
 While these experiments were being performed, ongoing work in our lab 
identified Wnt3a and BMP4 as sufficient for lung specification and found that FGF2 
promoted thyroid specification at the expense of the lung lineage (Maria Serra et al., in 
submission). Building on this result, we performed additional experiments where we 
specified cells using this new media containing only Wnt3a and BMP4 in the 
specification stage (Figure 3.5d). After specification, sorted Nkx2-1GFP+ progenitors 
(Figure 3.5e) were replated in three-dimensional Matrigel culture in FGF2+10 media 
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(Figure 3.5f)129. Sorted single cells proliferated within 5 days to form large Nkx2-1GFP+ 
luminal spheres containing beating cilia in a subset of cells (Figure 3.5g and data not 
shown). Cultures were treated with 4-OH-tamoxifen for 48 hours, at which point a subset 
of cells coexpressed Nkx2-1GFP and Cc10tdTomatoTr at an appreciably higher efficiency than 
the previous lung/thyroid mixed protocol (Figure 3.5h and data not shown). Ongoing 
experiments seek to test the enrichment of Cc10 expression in sorted tdTomato+ cells 
differentiated from iPSCs, with the goal of further validating this reporter system in vitro. 
We next sought to test whether Flk1 can be used to identify Cc10+ cells derived 
from iPSCs. We again purified and replated Nkx2-1GFP+ cells at day 15 and harvested 
tamoxifen-treated organoids at day 23. In this preliminary experiment, flow cytometric 
analysis of this population for Nkx2-1GFP, Cc10tdTomatoTr, and Flk1 protein expression 
revealed that 88.6% of cells remained Nkx2-1GFP+ at this stage, of which 6.1% of these 
expressed Cc10tdTomatoTr and 4.7% were Flk1+ (Figure 3.6a-b). Gating specifically for the 
Flk1+Nkx2-1GFP+ population resulted in an enrichment of Cc10tdTomatoTr expression to 
52.7%, representing a fold change enrichment of 8.6 over ungated. In contrast, gating for 
the Nkx2-1GFP+Flk1- population depleted Cc10tdTomatoTr expression to 2.5% (Fold change: 
0.4, Figure 3.6b). This result supports the conclusion that Flk1 is expressed on a fraction 
of Cc10tdTomatoTr+ cells derived in vitro from iPSCs and can be used to enrich for this 
population by cell sorting. Future work will seek to test whether Flk1 sorting will enrich 
for club cells in the absence of a reporter system by tracking club-cell specific mRNA 
expression, including Cc10 and Scgb3a2. 
		
53 
Figure 3.5. In vitro directed differentiation of Nkx2-1GFP; CC10tdTomatoTrace iPSC line to lung club cells. 
(a) Schematic of directed differentiation to day 15 Nkx2-1GFP+ lung and thyroid 
progenitors. (b) Representative flow cytometry analysis at day 5 of differentiation 
showing coexpression of endodermal markers C-kit and Cxcr4. (c) RT-qPCR 
measurement of fold change (2-ΔΔCt) of mRNA expression (compared to undifferentiated 
iPSCs) is shown in picked Nkx2-1GFP+;tdTomatoHigh and tdTomatoLow cells on Day 32. 
(d) Schematic of new directed differentiation protocol to day 15 Nkx2-1GFP+ lung 
progenitors. (e) Representative flow cytometry analysis of day 15 cells showing 
generation of a population of Nkx2-1GFP lung progenitors and representative sorting gate 
for replating. (f) Schematic of outgrowth conditions for cells sorted as indicated in (e). (g) 
Representative image of Nkx2-1GFP+ lung epithelial sphere on Day 21 prior to tamoxifen 
treatment. (h) Representative image of Day 22 sphere post tamoxifen treatment with cells 
coexpressing Nkx2-1GFP and Cc10tdTomatoTrace. 
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Figure 3.6. Enrichment of iPSC-derived Cc10tdTomatoTrace+ cells by Flk1 staining. 
(a) Flow cytometry analysis of Day 22 tamoxifen treated cells showing expression of 
Flk1 in the Nkx2-1GFP+ lung lineage and gating strategy for enrichment of Cc10tdTomatoTr 
expression. (b) Quantification of Cc10tdTomatoTr enrichment by gating for Flk1+ cells. 
“Ungated” fraction represents all Nkx2-1GFP+ cells. 
 	
III.4. Discussion and future directions 
 Our results demonstrate the expression of the VEGF receptor Flk1 
(VEGFR2/KDR) in airway club cells during a defined developmental window between 
E16.5 and early postnatal life. As Flk1 (outside of the hepatic endoderm) is currently 
thought to primarily mark mesodermal lineages, this finding extends our current 
understanding of the potential signals involved in airway development. In particular, as 
expression of this receptor is initiated in the epithelium near the time of club cell 
specification (approximately E16.5), this result suggests that the VEGF signaling 
pathway may play a currently undescribed role in the specification, maintenance or 
proliferation of this lineage in normal airways or in the interactions of club cells with 
other neighboring cell types. Future studies will seek to test the role of this pathway in 
club cell differentiation to provide additional insight into the relationship between VEGF 
signaling and airway epithelial development. In particular, we have begun initial 
experiments using a mouse line with a Flk1 gene flanked by LoxP sites crossed to a Shh-
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Cre mouse line to specifically delete Flk1 in the ventral foregut endoderm but results thus 
far have been inconclusive. For example, initial results from this experiment suggested 
that deletion of Flk1 in this region may not have any impact on club cell specification or 
normal airway epithelial development, but initial observations suggested that conditional 
Flk1-/- (cFlk1-/-) mice may have larger hearts than their cFlk1+/- counterparts. Follow up 
studies were confounded by unclear genotyping results, and thus a potential cardiac 
phenotype resulting from lung epithelial-specific deleteion of Flk1 remains inconclusive. 
Due to these concerns, we believe that the mechanistic role of airway Flk1 expression in 
mouse development remains an interesting question that still requires further careful 
application of genetic mouse models such as the one described here before any 
conclusions can be made regarding potential functional roles for airway epithelial Flk1 
expression.  
 Moving away from this in vivo model, we additionally describe the generation of 
an Nkx2-1GFP;CC10tdTomatoTrace reporter mouse and iPSC line and demonstrate the 
successful differentiation of this line to labeled Nkx2-1+Cc10+ airway club cells in vitro. 
This finding extends our previous work describing a protocol to generate lung epithelial 
cells from mouse ESCs by showing that we can track and purify specific mature lung 
epithelial cell types using this model. Future work will use this line to track, purify, and 
characterize the differentiation of airway club cells in vitro to understand at high 
resolution the signaling pathways that regulate murine club cell development and explore 
the characteristics of this important lung cell type. 
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 Finally, we use our Nkx2-1GFP;CC10tdTomatoTrace iPSC line to demonstrate that Flk1 
can be used to enrich for airway club cells in in vitro directed differentiation, allowing for 
the exploration of reporter-free models of club cell development. In particular, future 
work will rely on our human directed differentiation system described in Chapter IV to 
test whether Flk1 (KDR) similarly marks club cells derived from human PSCs. In this 
case, KDR could to be used to purify cells derived in vitro from diverse  hPSC lines (e.g. 
from patients with lung disease involving secretory lineages such as asthma or COPD) 
without requiring the use of a reporter, opening avenues for improved in vitro disease 
modeling.
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IV. TEMPORAL OSCILLATIONS IN WNT SIGNALING DRIVE THE 
DIFFERENTIATION OF FUNCTIONAL HUMAN AIRWAY EPITHELIUM 
FROM PLURIPOTENT STEM CELLS 
Please note - the majority of chapter was published in the journal Cell Stem Cell: 
McCauley et al., Efficient Derivation of Functional Human Airway Epithelium from 
Pluripotent Stem Cells via Temporal Regulation of Wnt Signaling, Cell Stem Cell (2017), 
http://dx.doi.org/10.1016/j.stem.2017.03.001 
 	
IV.1. Introduction 
Rationale 
Directed differentiation of functional lung epithelial cell types from human pluripotent 
stem cells (PSCs) holds promise for in vitro modeling of complex respiratory diseases 
and for future cell-based regenerative therapies.  Recent studies, including our own, have 
demonstrated that a heterogeneous mixture of diverse lung epithelia accompanied by 
non-lung lineages can be simultaneously “co-derived” from PSCs differentiated in vitro 
for several weeks or months129,130,144-150. However, many pulmonary diseases, such as 
cystic fibrosis, have their primary effects within distinct regions of the lungs and their 
constituent cellular subtypes. The heterogeneity of current differentiation outcomes 
therefore potentially hampers attempts to apply these PSC-based models to recapitulate 
pulmonary disease and test therapies in vitro. While recent cell sorting methods have 
enabled the derivation of more homogenous populations of lung epithelial progenitor 
cells or their differentiated progeny from human PSCs (hPSCs)136,147,148 , the consistent 
derivation of well-defined, mature functional lineages from these progenitors for 
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effective disease modeling has remained challenging, due in part to heterogeneous or 
stochastic differentiation in protocols that can depend on many weeks or months of cell 
culture.  
One approach to realize the promise of hPSC model systems for studying diseases 
affecting specific cellular subtypes is to engineer in vitro methods that more closely 
mimic in vivo developmental cell fate decisions. In contrast to current prolonged in vitro 
approaches, in vivo lung development is a tightly controlled process, where chaotic 
heterogeneity is minimized by signaling cascades that act cyclically in a regiospecific 
manner during narrow stage-dependent windows of time to precisely and rapidly promote 
appropriate cell fates while suppressing alternate fate options 151. The patterning of early 
lung epithelial progenitors in vivo in mouse embryos is a classic example of this 
phenomenon, since soon after lineage specification of primordial lung epithelial 
progenitors, indicated by emergence of Nkx2-1+ endoderm, their descendants located at 
advancing distal lung bud tips are faced with the fate option of either maintaining a distal 
progenitor phenotype or surrendering this fate as they move away from this distal niche 
to assume a proximal airway cell fate45. Through these fate decisions, the branching lung 
airways are patterned post-specification along a proximodistal axis, which is canonically 
defined by the expression of key transcription factors Sox2 in the proximal developing 
airway and tracheal epithelium and Sox9 in the budding distal tips48,152. Since this precise 
spatiotemporal segregation of Sox2 and Sox9 as canonical proximal and distal lung 
markers, respectively, has been described in developing mouse lungs it remains unclear 
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whether these markers may be similarly used as equally faithful proximal-distal epithelial 
patterning markers in early human lung development. 
Recreating the tightly controlled proximodistal patterning of lung cells during in 
vitro differentiation of iPSC-derived NKX2-1+ progenitors has been difficult in part due 
to the plethora of developmental signaling pathways that have been described in mouse 
models as being important to this process, including Wnt, FGF, BMP, TGFβ , RA, 
SHH, and Notch signaling20,25-37. In particular, it has been noted that these pathways 
exhibit high levels of temporal and regional specificity by which they each promote the 
migration, differentiation, and maturation of specific cell types at the expense of others. 
Here we develop an approach for modulating the cell fate decisions of hPSC-
derived primordial lung progenitors in a manner that recapitulates in vivo development, 
resulting in the synchronized modulation of proximal airway vs. distal alveolar epithelial 
patterning. Our method significantly differs from prior attempts147 by inducing rapid 
airway differentiation in response to changes in canonical developmental signaling 
pathways that act intrinsically on lung progenitors. As predicted by in vivo mouse genetic 
models20,27,42,153, in human PSC lung developmental model systems we find the Wnt 
signaling pathway to be an over-arching regulator of proximodistal epithelial patterning. 
Withdrawal of Wnt activation promotes swift emergence of proximal over distal 
epithelial fates from primordial NKX2-1+ progenitors, whereas maintenance of Wnt 
signaling promotes distal epithelial fates while suppressing proximal fates. The end result 
of this approach is the reliable production of “epithelial-only” airway organoids that 
derive directly from NKX2-1+ precursors and contain diverse airway epithelial cell types. 
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Furthermore, when generated from cystic fibrosis patient-specific iPSC lines, either 
before or after gene editing to correct the CFTR genetic lesion responsible for the 
disease, these organoids allow precise interrogation of mutant vs corrected CFTR 
function through forskolin-induced epithelial sphere swelling assays. This human 
developmental model system thus facilitates disease modeling and drug screening for a 
variety of genetic diseases affecting the airway epithelium, exemplified by cystic fibrosis.  
Additional Background: Activating and Measuring Canonical Wnt Signaling 
Wingless/Wnt proteins mediate a highly conserved signaling pathway with 
critical roles in embryonic development, in particular though control of downstream 
genes regulating fate as well as proliferation and cell polarity. Although activation of Wnt 
signaling via Wnt ligand binding has diverse effects, one of the most well-characterized 
is canonical Wnt signaling, or the transcriptional changes effected by Wnt-dependent 
translocation of beta-catenin to the nucleus where it acts as a transcriptional coactivator. 
Although canonical Wnt signaling is highly complex, it can be briefly understood 
as is summarized in Figure 4.1. In the absence of Wnt ligand, β-catenin is phosphorylated 
and bound in a “destruction complex” containing glycogen synthase kinase 3β (GSK3β), 
Axin, and adenomatosis polyposis coli (APC), which sequesters this transcriptional 
coactivator from the nucleus and promotes ubiquitination and degredation of this protein. 
When Wnt ligands bind to cells, they interact with a Frizzled family member G-protein 
coupled receptor (Fzd) and a LRP5/6 coreceptor, forming a large “receptor complex.” 
The protein Disheveled (Dvl) is recruited to this complex and activated by 
phosphorylation, leading to disruption of the destruction complex by recruitment of Axin 
		
61 
to the now-phosphorylated LRP receptor and displacement of GSK3β from the complex. 
Loss of the destruction complex and disruption of the kinase activity of GSK3β leads to 
accumulation of dephosphorylated β-catenin in the cytoplasm and subsequent 
translocation of this protein to the nucleus. In the nucleus, β-catenin displaces the 
inhibitor Groucho and binds to T-cell factor / lymphoid enhancer factor (TCF/LEF) 
transcription factors as well as other cofactors, including Crebs binding protein (CBP) 
and p300. This results in the activation of downstream target genes. This pathway is 
discussed in depth on The Wnt Homepage (wnt.stanford.edu) and reviewed in Clevers 
and Nusse, 2012154. 
In this work, the main method used to activate canonical Wnt signaling is the 
small molecule CHIR99021 (CHIR), which is a potent inhibitor of GSK3β and 
consequently leads to release of β-catenin from the destruction complex and the related 
downstream consequences. Since GSK3β has effects in other pathways, we also sought to 
ensure that CHIR was having the intended effect of activating canonical Wnt signaling in 
our in vitro system. Similarly, overexpression of activated beta-catenin by lentivirus can 
directly activate canonical Wnt signaling155, but we did not see a profound effect of this 
method on our cells. We also observed little effect on Wnt signaling from the addition of 
canonical Wnt ligands, such as Wnt3a, to our culture system, possibly due to the tight 
regulatory control of this signaling pathway in cells.  
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Figure 4.1. Overview of Wnt signaling pathway. 
The Wnt signaling pathway controls transcription by promoting the nuclear localization 
of dephosphorylated β-catenin via a complex, coordinated signaling cascade. Figure from 
WormBook (http://www.wormbook.org/chapters/www_wntsignaling/wntsignaling.html). 
 
There are various approaches to tracking the activation of Wnt signaling in vivo 
and in vitro. One simple population-based approach is to track the transcriptional levels 
of Axin2, as this protein inhibits Wnt signaling and this gene is consequently involved in 
a tight negative regulatory loop by which it is upregulated in response to Wnt 
activation156. Additionally, as β-catenin activates transcription in canonical Wnt signaling 
via binding to and activating TCF/LEF transcription factors, another common approach 
to track Wnt signaling on a per-cell basis is the use of constructs containing repeated 
TCF/LEF DNA binding sites upstream of a reporter such as luciferase or a fluorescent 
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protein157. In this work, we use lentiviral constructs containing 7 TCF binding sites 
upstream of an mCherry fluorescent protein to read out Wnt activation in response to 
CHIR158. More detail in Results, below. 
 
IV.2. Materials and Methods 
Some methods used to generate the results in this section, including 
immunofluorescence, quantitative real time PCR, and directed differentiation of mESCs 
to Nkx2-1+ lung epithelium, are described in Chapter III. 
Human ESC/iPSC Reporter Line Generation and Maintenance 
The NKX2-1GFP iPSC lines (“BU3” and “C17”) were derived from a normal 
donor and an individual with cystic fibrosis carrying a published compound 
heterozygeous CFTR genotype159, respectively. Both lines were targeted with an NKX2-
1GFP fluorescent reporter using CRISPR and TALENs technologies, respectively, as 
described previously136. Gene editing to correct one CFTR allele of patient-derived 
ΔF508/ΔF508 cystic fibrosis lines (RC2 202 and RC2 204) was described previously.159 
The RUES2 human embryonic stem cell line was a generous gift from Dr. Ali H. 
Brivanlou  of The Rockefeller University. All human PSC lines were maintained in 
feeder-free culture conditions in 6-well tissue culture dishes (Corning, Corning, NY) on 
growth factor reduced Matrigel (Corning) in mTeSR1 medium (Stem Cell Technologies, 
Vancouver, Canada) by passaging with ReLeSR (Stem Cell Technologies) and Gentle 
Cell Dissociation Reagent (Stem Cell Technologies). All human ESC/iPSC lines used 
were characterized for pluripotency and were found to be karyotypically normal. Further 
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details of iPSC derivation, characterization, and culture are available for free download at 
http://www.bu.edu/dbin/stemcells/protocols.php. 
Directed Differentiation of hPSCs 
NKX2-1+ lung progenitors were generated from hPSCs as described previously 
129,136,145. Briefly, definitive endoderm was induced with STEMdiff Definitive Endoderm 
Kit (Stem Cell Technologies) for 72 hours (day 0 – 72 hours; this differs from the 
numbering convention used by the manufacturer’s protocol, which describes this period 
as day 1 – day 4). Endoderm-stage cells were dissociated and passaged in small clumps to 
growth factor reduced Matrigel-coated (Corning) tissue culture plates (Corning) in base 
media of IMDM (ThermoFisher, Waltham, MA) and Ham’s F12 (ThermoFisher) with 
B27 Supplement with retinoic acid (Invitrogen, Waltham, MA), N2 Supplement 
(Invitrogen), 0.1% bovine serum albumin Fraction V (Invitrogen), monothioglycerol 
(Sigma, St. Louis, MO),  Glutamax (ThermoFisher), ascorbic acid (Sigma), and primocin 
(complete serum free differentiation medium, cSFDM129,135) containing 10 µM 
SB431542 (Tocris, Bristol, United Kingdom) and 2 µM Dorsomorphin (Stemgent, 
Lexington, MA) for 72 hours (72 hours – 144 hours) to pattern cells towards anterior 
foregut endoderm. Cells were then cultured for 9-11 additional days (typically, 144 hours 
- day 15) in cSFDM containing 3 µM CHIR99021 (Tocris), 10 ng/mL recombinant 
human FGF10 (rhFGF10, R&D Systems, Minneapolis, MN), 10 ng/mL recombinant 
human KGF (rhKGF, R&D Systems), 10 ng/mL recombinant human BMP4 (rhBMP4, 
R&D Systems), and 50 nM retinoid acid (RA, Sigma) or with CHIR, BMP4, and RA 
alone (for organoid immunostaining),  to induce a lung epithelial progenitor fate. Doses 
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of growth factors were determined based on previously published directed differentiation 
protocols 129,135,145. Lung epithelial specification was evaluated at day 15 of 
differentiation by flow cytometry for NKX2.1GFP expression, expression of surrogate cell 
surface markers CD47hi/CD26-, or nuclear NKX2-1 protein content. Surface marker 
expression was evaluated at this stage of differentiation using a human cell surface 
marker screening panel (BD Biosciences, San Jose, CA). 
Neuroectodermal NKX2-1GFP+ cells were generated as described 
previously{Hawkins:2017vz} using STEMdiff Neural Induction Medium (Stem Cell 
Technologies) according to the manufacturer’s protocol with additional puromorphamin 
(Stemgent, 2 uM) supplementation from Day 6 to Day 12-15. NKX2-1GFP+ cells were 
purified by cell sorting at Day 12-15. 
Purification of NKX2-1+ Lung Progenitors by Cell Sorting 
Cells grown in two-dimensional culture were harvested by incubation with 0.05% 
Trypsin-EDTA for 10-20 minutes at 37°C. Cells cultured in three-dimensional growth 
factor reduced Matrigel were harvested by incubation with 2 mg/mL dispase 
(ThermoFisher) for 30-60 minutes at 37°C then subsequent incubation with 0.05% 
trypsin at 37°C until a single cell suspension was achieved. Cells were washed with 
media containing 10% fetal bovine serum (FBS, ThermoFisher.) Harvested cells were 
spun at 300 RCF for 5 minutes at 4°C and resuspended in buffer containing Hank’s 
Balanced Salt Solution (ThermoFisher), 2% FBS and 10µM Y-27632 (Tocris) and 
stained with propidium iodide (ThermoFisher) or calcein blue AM (ThermoFisher) for 
dead cell exclusion during flow cytometry. Live cells were sorted on a high speed cell 
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sorter (MoFlo Legacy, Beckman Coulter, Pasadena, CA) at the Boston University 
Medical Center Flow Cytometry Core Facility based on NKX2-1GFP expression or by 
staining for CD47 (Biolegend) and CD26 (Biolegend) and gating for CD47hi/CD26-. 
Although nearly 100% of all differentiated cells are CD47+ at day 15 of directed 
differentiation, isolating cells in the region of the CD47 cloud brighter than the CD26+ 
population (CD47hi, representative gate depicted in Figure S5a) results in significant 
enrichment of the NKX2-1+ lung progenitor population (Figure 6b, Figure S5a and 
Hawkins et al., in press136) 
Post-Specification Patterning of Lung Epithelial Progenitors 
Day 14-16 cells from the lung progenitor directed differentiation protocol were 
harvested with 0.05% Trypsin-EDTA (Invitrogen) and replated in small clumps to 
improve survival (for unsorted experiments) or after single cell sorting in either growth 
factor reduced Matrigel-coated tissue culture dishes in two-dimensional culture (unsorted 
clumps only) or in three-dimensional growth factor reduced Matrigel drops (both 
unsorted clumps and sorted single cells).  
Matrigel drops were formed by resuspending cells directly in undiluted growth 
factor reduced Matrigel matrix, pipetting 50-100 µL into each well, and allowing the 
Matrigel / cell mixture to gel for 30 minutes at 37°C. Cell drops were then covered 
completely with growth medium. 
Post-specification culture conditions were determined by the addition of growth factors to 
cSFDM. For patterning experiments, growth factors were added to a base media 
containing 10 ng/mL rhFGF10 (“Base”) and additional factors detailed in the results text. 
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For concentrations of growth factors required for each experiment, see Table 4-3. Doses 
of growth factors were determined based on previously published directed differentiation 
protocols129,135,145 as well as dose-response experiments using 7XTCF lentiviral reporters 
for CHIR99021 (Figure S2d-e). Cells were additionally cultured with 10µM Y-27632 
(Tocris) for 24 hours after replating. 
Growth Factor Stock Concentration Final Concentration 
CHIR99021 3 mM 3 µM 
rhBMP4 10 mg/mL 10 µg/mL 
Dorsomorphin 2 mM 2 µM 
FGF2 250 mg/mL 250 µg/mL 
FGF10low 100 mg/mL 10 µg/mL 
FGF10high 100 mg/mL 100 µg/mL 
rhTGFβ 10 mg/mL 10 µg/mL 
SB431542 10 mM 10 µM 
DAPT 10 mM 2 µM 
 
Table 4.1. Growth factor concentrations. 
The final protocol for generating rapidly proximalized NKX2-1+ lung epithelium 
was replating unsorted or sorted cells for 4 days of culture post-specification in cSFDM 
containing 10 ng/mL FGF10. Sorted cells were cultured with additional factors: 50 nM 
dexamethasone (Sigma), 0.1 mM 8-Bromoadenosine 3′,5′-cyclic monophosphate sodium 
salt (Sigma) and 0.1 mM 3-Isobutyl-1-methylxanthine (IBMX) (Sigma) (DCI), and Y-
27632. Cells were analyzed for expression of proximal markers 4 days post-replating in 
FGF10 media. 
For organoid experiments, cells were cultured in “CFK media” containing 3 µM 
CHIR99021, 10 ng/mL rhFGF10, and 10 ng/mL rhKGF or “2+10 media” containing 250 
ng/mL recombinant human FGF2 (rhFGF2, R&D Systems) and 100 ng/mL rhFGF10. We 
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further supplemented these medias with DCI and Y-27632.  All organoid formation 
experiments were performed on replated purified, single cell lung progenitors. 
Therefore, in the final protocol for the generation of proximalized organoids, single 
sorted NKX2-1+ cells were replated as 50,000-100,000 cells per well cultured in cSFDM 
with FGF2 (250 ng/mL), FGF10 (100 ng/mL), DCI, and Y-27632 for at least one week 
post-sort prior to analysis. Proximalized organoids were maintained for up to 6 weeks 
after sorting, with media changed every other day. Ciliation was induced in proximalized 
organoids by Notch inhibition using DAPT (2 µM, Sigma) in organoids after outgrowth 
least 2 weeks post-sort. Generation of motile cilia was observed by 2 weeks post-DAPT 
treatment. 
Images of cultured organoids, including videos, were taken on a Keyence (Osaka, 
Japan) BZ-X700 fluorescence microscope. Z-stack images were processed using full 
focus image analysis using Keyence software. 
For formation of ALI cultures, proximalized cells were trypsinized and replated in 
two-dimensional culture on TransWell inserts (Corning) at a confluency of 100,000 
cells/cm2. Expansion was performed in PneumaCult ALI media (Stem Cell Technologies) 
containing dexamethasone to replace hydrocortisone with additional SMAD inhibition by 
Dorsomorphin (2 µM) and SB431542 (10 µM) until confluent 160. After expansion of 
cells to confluence, media was removed from the top chamber and cells were 
differentiated in PneumaCult ALI media with dexamethasone but without SMAD 
inhibition. Motile ciliated cells were observed by one week post-induction of ALI 
differentiation. ALI cultures were characterized by immunofluorescent staining for 
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acetylated alpha tubulin, Hoescht, and F-actin (phalloidin, Applied Biosystems) and z-
stack images were taken on a confocal microscope (Zeiss). Orthogonal and maximum 
intensity Z-projections were generated using ImageJ. 
Gene Set Enrichment Analysis 
Gene set enrichment analysis was performed using MSigDB v5.1 hallmark gene 
sets (http://software.broadinstitute.org/gsea/index.jsp)161,162 on our previously described 
microarray database (Hawkins et al., in press136; all raw data files can be downloaded 
from the gene expression ombinus, GEO#: GSE83310). Significant pathways were 
considered those with Benjamini-Hochberg false discovery rate-adjusted p value (FDR) < 
0.1. 
Generation of Lentiviral Reporters for Wnt Signaling 
VSV-G pseudotyped lentiviral plasmids for β-catenin overexpression (EF1alpha-
betacatenin(deltaGSK)-SV40-mCherry, AddGene Plasmid #23412)155 and the canonical 
Wnt reporter 7xTcf-mCherry (Addgene Plasmid #24315)158 were a generous gift from 
Dr. Roel Nusse (Stanford University, Stanford, CA). Lentiviral particles were packaged 
in 293T cells using a five-plasmid system as previously described163. To calculate titers, 
FG293 cells were transduced with concentrated virus in 10% FBS with polybrene (5 
µg/mL) and transduction efficiency was quantified after 72 hours by flow cytometry. For 
the 7XTCF-mCherry virus, cells were treated for 48 hours of 3 µM CHIR99021 prior to 
titering by flow cytometry. For each experiment, parallel wells were infected with the 
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same MOI of a pHAGE EF1a-mCherry virus as a control for infection efficiency and 
nonspecific effects of lentiviral infection. 
Immunofluorescence Microscopy of Cultured Cells 
Cells for immunofluorescence microscopy were cultured on glass coverslips 
(ThermoFisher). Cultured cells were fixed with fresh 4% paraformeldehyde and stained 
as described previously135. Briefly, cells were permeabilized with 0.3% Triton-X (Sigma) 
for 10 minutes at room temperature then blocked with 4% normal donkey serum (Sigma) 
for 30 minutes at room temperature. Cells were incubated with primary antibodies 
(detailed in Table 4-2) overnight at 4°C, washed, and incubated with secondary 
antibodies for 30-60 minutes at room temperature. All secondary antibodies were 
conjugated to Alexa Fluor 488, Cy3, or Alexa Fluor 647 (Jackson Immunoresearch, 
1:500). After antibody staining, nuclei were stained with Hoescht dye (ThermoFisher, 
1:500). Coverslips with cells were mounted on glass slides using Prolong Diamond Anti-
Fade Mounting Reagent (ThermoFisher) and imaged on a Nikon (Tokyo, Japan) 
deconvolution microscope. 
Three-dimensional organoids were harvested by incubating for 1 hour with 
dispase and fixed with fresh 4% paraformaldehyde. Whole organoids were stained as 
described for cultured cells, with slightly longer permeabilization, blocking wash, and 
antibody incubation steps. For whole mount imaging, organoids were mounted on cavity 
slides and visualized with a Zeiss (Jena, Germany) confocal microscope. 
Quantification of nuclear colocalization was performed using Nikon NIS 
Elements software using the Object Count function. 3-5 areas from each slide were 
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analyzed for each replicate. The total image area where NKX2-1 and SOX2, SOX9, or 
P63 overlapped was divided by the area containing only the NKX2-1 stain. 
Antibody Company Catalog Number 
Rabbit monoclonal to NKX2-1 
(clone EP15847) 
Abcam ab76013 
Mouse monoclonal to NKX2-1 
 (clone 8G7G3/1) 
Abcam ab72876 
Mouse monoclonal to FOXA2 
(clone HNF-3B) 
Santa Crus sc-101060 
Mouse monoclonal to SOX2 
(clone O30-678) 
BD 
Biosciences 
561469 
Goat polyclonal to SOX2 Santa Cruz sc-17320 
Mouse monoclonal to P63 
(clone 4A4) 
BioCare 
Medical 
163 
Rabbit polyclonal to P63 Santa Cruz sc-8344 
Chicken polyclonal to KRT5 Biolegend 905901 
Mouse monoclonal to EPCAM 
(clone AUA1) 
Abcam ab20160 
Rabbit polyclonal to Pro-SPB Seven Hills WRAB-
55522 
Rabbit monoclonal to SCGB3A2 
(clone EPR11463) 
Abcam ab181853 
Mouse monoclonal to MUC5AC 
(clone 45M1) 
ThermoFisher MA1-38223 
Rabbit monoclonal to acetylated 
alpha-tubulin 
(clone D20G3) 
Cell Signaling 
Technologies 
5335 
Mouse monoclonal to CD26, PE 
conjugated 
(clone BA5b) 
Biolegend 302705 
Mouse monoclonal to CD47, PerCP-
Cy5.5 conjugated 
(clone CC2C6) 
Biolegend 323110 
 
Table 4.2. Primary Antibody Information 
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Forskolin-Induced Swelling of Organoids 
Swelling was induced in organoids at Day 22 – 35 of differentiation. Organoids grown in 
in three-dimensional Matrigel culture in the absence of cyclic AMP and IBMX were 
passaged to new droplets in 3 µL growth factor reduced Matrigel at least one day prior to 
swelling. For swelling analysis, organoids were incubated in media containing 5-10 µM 
forskolin (Sigma) and 10 µM calcein green (ThermoFisher) for 4 – 24 h at 37°C and 5% 
CO2. Whole well images were taken using a Keyence BZ-X700 fluorescence microscope 
at time of forskolin addition and 24 hours later and stitched using Keyence software. 
Videos were created by imaging every 15 minutes for 24 hours. Quantification of 
swelling area was performed from replicate wells images on the calcein green channel 
using ImageJ. Total well surface area covered by organoids was calculated based on 
thresholded images and the total well area of circular organoids (circularity = 0.5-1) were 
measured. If necessary, organoid edges were smoothed using a Gaussian blur filter prior 
to thresholding and watershedding. The well area at time = 0 was set to 1. Images were 
again analyzed at 3 and 24 hours post-forskolin addition and the ratio of the post-swelling 
area to the original area was calculated. Statistics were calculated from separate wells of 
organoids, with each value comprising 20-50 individual organoids. 
Statistical Methods 
Statistical methods relevant to each figure are outlined in the figure legend. 
Briefly, unless indicated otherwise in the figure legend, unpaired, two-tailed Student’s t-
tests were used to compare quantitative analyses comprising two groups of n=3 or more 
samples, where each replicate (“n”) represents either entirely separate differentiations 
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from the pluripotent stem cell stage or replicates differentiated simultaneously and sorted 
into separate wells. Further specifics about the replicates used in each experiment are 
available in the figure legends. In these cases, a Gaussian distribution and equal variance 
between samples was assumed as the experiments represent a large number of random 
samples of the measured variable. As we anticipated that biologically relevant differences 
between conditions would have a large effect size and due to the large technical burden 
of directed differentiation experiments, we set our sample size threshold to at least 3 
replicates to ensure our samples were large enough to perform t-tests to compare the 
populations and observe predicted differences. The p-value threshold to determine 
significance was set at p=0.05. Data for quantitative experiments is typically represented 
as the mean with error bars representing the standard deviation or standard error of the 
mean, depending on the experimental approach. These details are available in the figure 
legends. For analysis of dose escalation experiments, an ordinary one-way ANOVA with 
post test for linear trend to test the linear trend in the mean value at the indicated doses 
from left to right. 
IV.3. Results 
Screening Developmental Signaling Pathways Reveals Contribution from Wnt and BMP 
Signaling to Proximodistal Patterning of hPSC-Derived Lung Epithelium 
To screen for potential mechanisms regulating human lung epithelial patterning after lung 
lineage specification, we sought to employ an in vitro lung development model system 
that uses sequential medias in a stepwise, stage-specific approach to recapitulate the 
lineage specification of relatively undifferentiated (primordial) FOXA2+NKX2-1+ 
		
74 
endodermal lung progenitors via anterior foregut endoderm from mouse or human 
pluripotent stem cells (PSCs) (Figure 4.2a, Figure 4.3a)129,136,145,164 .  Using this approach, 
we derived NKX2-1+ lung epithelial progenitors at varying efficiencies from several 
hPSC lines, including RUES2 (untargeted) and an iPSC line (hereafter C17) carrying a 
green fluorescent protein (GFP) reporter targeted to NKX2-1, the first gene locus 
activated in developing endoderm at the time of lung lineage specification (hereafter 
NKX2-1GFP, Figure 4.2b, Figure 4.3b) 136. Using these lines, we found that differentiated 
lung progenitors were enriched for NKX2-1 and FOXA2 expression (Figure 4.2c) and 
did not express appreciable markers of other NKX2-1+ lineages (thyroid, PAX8; neural, 
OLIG2) in comparison to neuroectodermal and thyroid controls (Figure 4.2c). Nearly 
100% of NKX2-1GFP+ cells were EPCAM+ (Figure 4.2d), and did not express markers of 
other non-endodermal lineages including PDGFRα, CD31, and CD45 (Figure 4.2e). 
Although these NKX2-1GFP+ progenitors are initially undifferentiated or 
primordial at the time of their emergence in culture (days 9-15 136, further time in culture 
in media supplemented with CHIR99021, FGF10 and KGF results in their differentiation 
into a heterogeneous population of cells expressing markers consistent with multiple lung 
lineages characteristic of both proximal airway and distal alveolar epithelia, including 
SOX2, SOX9, TP63, SFTPB, CFTR, SFTPC, FOXJ1, and SCGB3A2136. 
To test whether we could efficiently induce a proximal vs distal program in iPSC-
derived lung progenitors we modulated key developmental pathways beginning on day 
15 of differentiation in our model system (Figure 4.3c-e), and we monitored changes in 
SOX2 and SOX9 expression that might suggest coordinated proximal vs distal patterning 
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changes in purified NKX2-1GFP+ cells within 4 days of treatment. At day 15, post-lung 
specification, we cultured cells in a base media of “low dose” (10 ng/mL) FGF10 to 
promote proliferation without strongly inducing patterning42. From this base media, we 
stimulated the following pathways: Wnt signaling via the potent GSK3β inhibitor 
CHIR99021, hereafter CHIR; FGF signaling using FGF2 or high dose (100 ng/mL) 
FGF10; BMP signaling using BMP4; and TGFβ signaling using TGFβ1.  
We found that conditions containing CHIR resulted in significantly decreased SOX2 and 
increased SOX9 expression in sorted NKX2-1GFP+ cells, suggesting abrogated proximal 
and increased distal patterning within 4 days (day 19; Figure 4.3e). Suppression of 
proximal cell fate by CHIR was further supported by decreased expression of the highly-
specific proximal lung epithelial marker, SCGB3A2. BMP signaling activation also 
suppressed SOX2 and SCGB3A2 expression while permitting SOX9 expression, 
although to a lesser extent than Wnt activation. Inhibition of BMP signaling with the 
SMAD1/5/8 inhibitor, Dorsomorphin, significantly blocked CHIR induced distal 
patterning (CHIR vs CHIR+Dorso p=1x10-6). Addition of the Wnt inhibitor, XAV939, 
had no effect in conditions without CHIR (data not shown), suggesting low basal Wnt 
signaling. High dose FGF10 resulted in smaller but statistically significant increased 
SOX9 expression (Figure 4.3e). Concordantly, treatment with escalating doses of FGF10 
together with CHIR resulted in additionally increased distal (SOX9) and decreased 
proximal (SOX2) patterning (Figure 4.2f). In contrast, we found that TGFβ signaling had 
no significant effect on patterning markers (Figure 4.2g). 
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Taken together, this initial signaling pathway screen suggested that hPSC-derived 
lung epithelium responds within 4 days to signaling cues and that Wnt activation via 
CHIR potentially maintains distal over proximal epithelial patterning early post-lung 
specification. These patterning changes in human cells are consistent with prior mouse 
genetic studies suggesting modulation of Wnt activity impacts lung proximodistal 
patterning during development20,25-27,42,51,52. 
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Figure 4.2. Directed differentiation of lung epithelial progenitors. 
(a) Immunofluorescence staining of day 15 cells for NKX2-1 and FOXA2. (b) 
Quantification of differentiation efficiency of C17 by NKX2-1GFP% and of RUES2 by 
intracellular NKX2-1 flow cytometry. Box and whisker plot; whiskers represent 
maximum and minimum value (C17: n=28 independent differentiations; RUES2: n=6 
independent differentiations). (continued on next page)  
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(c) Fold change of mRNA expression in iPSC-derived NKX2-1GFP+ cells on Day 15 
compared to cells differentiated in neural conditions or to primary adult thyroid tissue. 
Fold change measured over undifferentiated iPSCs by RT-qPCR (2-ΔΔCt). Bars represent 
mean ± S.D, n=3. *** p ≤ 0.001 by unpaired, two-tailed Student’s t-test. (d) Flow 
cytometry for EPCAM on day 15 differentiated cells. (e) FACS array results for CD24, 
CD31, CD45, PDGFRα, and CD26 on day 15 differentiated cells compared to NKX2-
1GFP expression. (f) Fold change of mRNA expression in iPSC-derived NKX2-1GFP+ cells 
on Day 19 treated with CHIR and escalating doses of FGF10 (as indicated). Fold change 
measured over undifferentiated iPSC by RT-qPCR (2-ΔΔCt). Bars represent mean ± S.D. 
(n=3). **p=0.0016 by ordinary one-way ANOVA post test for linear trend. For SOX2 
condition, p=0.0546. (g) Fold change of mRNA expression in iPSC-derived NKX2-1GFP+ 
cells on Day 19 treated with indicated growth factors from Day 15 to 19. Fold change 
measured over base condition by RT-qPCR (2-ΔΔCt). Bars represent mean ± S.D. (Base, 
+CHIR: n=6; others: n=3). Arrows indicate conditions containing CHIR99021. 
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Figure 4.3. Wnt and BMP4 signaling contribute to proximodistal pattering of hPSC-derived lung progenitors.  
(a) Schematic depicting directed differentiation protocol from hPSCs to NKX2-1+ lung 
progenitors. (b) Representative day 15 FACS plot showing NKX2-1GFP expression in C17 
cells. (c) Experimental approach for testing the effect of developmental pathways on 
proximodistal patterning (BMPi = BMP inhibition using Dorsomorphin, TGFβi = TGFβ 
inhibition using SB431542. (d) Schematic of murine branching lung depicting key 
proximodistal patterning markers. (e) RT-qPCR measurement of fold change (2-ΔΔCt) of 
mRNA expression is shown for day 0 iPSCs or NKX2-1GFP+ sorted cells on day 19 after 
treatment with indicated growth factors from day 15 to 19. Base media (day 19 control 
condition without supplements) is defined as fold change=1. Arrows indicate conditions 
containing CHIR99021. Bars represent mean ± S.D. (Base, +CHIR: n=6; others: n=3 
biological replicates of independent wells of a differentiation) * p ≤ 0.05, ** p ≤ 0.01, 
*** p ≤ 0.001, **** p ≤ 0.0001 by unpaired two-tailed Student’s t-test between test 
conditions and base. 
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Wnt Signaling is Required in a Stage-Dependent Manner for Normal Lung Epithelial 
Specification 
Having identified Wnt signaling as a putative patterning pathway, we sought to 
understand more about the stage-dependent role of this pathway in hPSC lung 
differentiation. By comparing iPSC-derived anterior foregut endoderm to purified NKX2-
1GFP+ progenitors at day 15 of differentiation through unbiased gene set enrichment 
analysis (GSEA) of their global transcriptomes, we identified 19 / 50 gene sets 
statistically upregulated in day 15 NKX2-1+ progenitors (FDR < 0.1), including Wnt / β-
catenin signaling (Table 4.3). Upregulation of the canonical target Wnt genes, AXIN2, 
NKD1, and LEF1 and downregulation of the Wnt inhibitor DKK1 were particularly 
predictive of Wnt activity as cells progress developmentally from anterior foregut to 
NKX2-1+ lung epithelial progenitors in this in vitro human model system  (Figure 4.4a). 
These changes were maintained until day 28 in NKX2-1+ cells cultured in media 
containing CHIR (Figure 4.5a). The faithfulness of AXIN2 as a canonical Wnt response 
reporter in this human system was further supported by separate experiments where 
lentiviral overexpression of phosphorylation-incompetent murine β-catenin155 in NKX2-
1+ progenitors resulted in upregulation of AXIN2 even in the absence of CHIR (Figure 
4.5b-c). Furthermore, lentiviral TCF reporters in FG293 cells confirmed that the dose of 
CHIR used at this stage and later differentiation (3 µM) was appropriate to induce Wnt 
activation without significant cytotoxicity (Figure 4.5d-e). 
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Name Size 
Normalized 
Enrichment 
Score 
FDR q-
value 
HALLMARK_TNFA_SIGNALING_VIA_NFKB 198 -1.8240852 0.006348201 
HALLMARK_HYPOXIA 200 -1.7880292 0.0037741 
HALLMARK_ANGIOGENESIS 36 -1.7711891 0.003735511 
HALLMARK_ESTROGEN_RESPONSE_EARLY 199 -1.7205737 0.006668388 
HALLMARK_UV_RESPONSE_DN 144 -1.5744675 0.030399535 
HALLMARK_BILE_ACID_METABOLISM 111 -1.5310853 0.042757373 
HALLMARK_PEROXISOME 102 -1.5136111 0.042757545 
HALLMARK_CHOLESTEROL_HOMEOSTASIS 72 -1.5047455 0.040901147 
HALLMARK_APOPTOSIS 160 -1.4711344 0.050714307 
HALLMARK_COAGULATION 135 -1.4658425 0.04762081 
HALLMARK_WNT_BETA_CATENIN_SIGNALING 42 -1.4453037 0.051528893 
HALLMARK_P53_PATHWAY 196 -1.4307697 0.05486355 
HALLMARK_IL2_STAT5_SIGNALING 197 -1.3720958 0.09474975 
HALLMARK_NOTCH_SIGNALING 32 -1.367708 0.09090935 
HALLMARK_INTERFERON_GAMMA_RESPONSE 198 -1.3676509 0.08493148 
HALLMARK_ANDROGEN_RESPONSE 100 -1.3614836 0.083667904 
HALLMARK_HEDGEHOG_SIGNALING 36 -1.3410127 0.09431362 
HALLMARK_ESTROGEN_RESPONSE_LATE 196 -1.3259907 0.09967242 
HALLMARK_INTERFERON_ALPHA_RESPONSE 97 -1.3192648 0.099256255 
HALLMARK_EPITHELIAL_MESENCHYMAL_TRANS
ITION 197 -1.2952383 0.11539885 
HALLMARK_IL6_JAK_STAT3_SIGNALING 87 -1.2755989 0.12782504 
HALLMARK_APICAL_JUNCTION 199 -1.255455 0.14274164 
HALLMARK_KRAS_SIGNALING_UP 198 -1.2520566 0.14006957 
HALLMARK_COMPLEMENT 198 -1.2445407 0.14189927 
HALLMARK_INFLAMMATORY_RESPONSE 199 -1.224236 0.16050687 
HALLMARK_FATTY_ACID_METABOLISM 155 -1.1272986 0.3016235 
HALLMARK_XENOBIOTIC_METABOLISM 198 -1.0933243 0.3609344 
HALLMARK_UV_RESPONSE_UP 158 -1.0775985 0.38219756 
HALLMARK_TGF_BETA_SIGNALING 52 -1.0613542 0.40488362 
HALLMARK_APICAL_SURFACE 44 -0.99059945 0.56656843 
HALLMARK_GLYCOLYSIS 198 -0.97763234 0.58223677 
HALLMARK_ALLOGRAFT_REJECTION 196 -0.9665041 0.5927925 
HALLMARK_PANCREAS_BETA_CELLS 40 -0.94818294 0.6248669 
HALLMARK_UNFOLDED_PROTEIN_RESPONSE 111 -0.89226073 0.74870694 
HALLMARK_MTORC1_SIGNALING 198 -0.82918364 0.86852586 
HALLMARK_HEME_METABOLISM 198 -0.7689398 0.9319405 
 
Table 4.3. Gene set enrichment analysis showing significantly upregulated pathways from Day 6 anterior foregut 
endoderm to Day 15 NKX2.1GFP+ cells. 
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Figure 4.4. Withdrawal of Wnt signaling activity post-lung specification leads to increased proximal patterning. 
 (a) Gene set enrichment analysis (GSEA) of microarray data indicating the Wnt/b 
catenin signaling pathway is upregulated in iPSC-derived day 15 lung progenitors. The 
gene expression heat map indicates the unbiased ranking of Wnt pathway genes 
differentially expressed by GSEA based on the MSigDB v5.1 Hallmark Wnt/β-Catenin 
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Signaling database comparing iPSC-derived day 6 (“Anterior Foregut Endoderm”, or 
“AFE”) cells and day 15 purified NKX2.1GFP+ cells. (continued on next page) 
Arrowheads indicate individual Wnt target genes anticipated to be most predictive of Wnt 
signaling activity. (b) Schematic of experiment showing manipulation of Wnt signaling 
from day 15 to 19. (c) RT-qPCR showing fold change in gene expression compared to 
day 0 (2-ΔΔCt) in day 19 NKX2-1GFP sorted cells after 4 days treatment +/-CHIR or 
rmWnt3a. Bars represent mean ± S.E.M. +CHIR: n = 9 biological replicates of 
independent wells within multiple differentiations, +rmWnt3a: n=3. (d) Fold change of 
mRNA expression in NKX2-1GFP+ cells on day 19 over undifferentiated iPSCs by RT-
qPCR (2-ΔΔCt). Unsorted cells were cultured with or without CHIR or rmWnt3a (SOX2, 
SOX9) from day 15-19 then sorted on day 19 for NKX2-1GFP expression. Bars represent 
mean ± S.E.M. (Biological replicates for each condition: CHIR treatment SOX2 n=9; 
SCGB3A2, P63: n=10; SOX9: n=6; MUC5AC, ETV5: n=3. For rmWnt3a, n=3). (c,d) * 
p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001 by unpaired, two-tailed Student’s t-
test.  (e) Representative immunofluorescence stains of NKX2-1 (green) and SOX2 or 
SOX9 (red) nuclear protein expression with DNA stain (Hoescht; blue) at day 19 with 
and without CHIR from day 15 - 19. Panels are images of the same cells stained for all 
three markers. Scale bars, 25 µm. (f) Quantification of NKX2-1, SOX2, and SOX9 
coexpression by intracellular flow cytometry (SOX2) or by colocalization calculated 
from staining in (e) (SOX9). Bars represent mean ± S.D., n=3. *p=0.03; ***p=0.0002 by 
unpaired two-tailed Student’s t-test. (g). Representative immunofluorescence stains for 
NKX2-1 (green) and P63 (red) nuclear protein expression with DNA stain (Hoescht; 
blue)  at day 19 with and without CHIR from day 15 - 19. Left panels and right panel: 
Scale bars, 50 µm. Second from right panel: Scale bars, 25 µm. (h) Quantification of 
NKX2-1 and P63 colocalization from staining in (g). Bars represent mean ± S.D., area 
calculated from 5 images of each of n=3 biological replicates. *p=0.01 by unpaired two-
tailed Student’s t-test. (i) Representative immunofluorescence images of NKX2-1 
(green), P63 (red) and KRT5 (white) at day 19 after culture without CHIR from day 15 to 
19. Arrowheads indicate NKX2-1/P63/KRT5 triple positive cells. Scale bars, 50 µm. See 
also Figure S2-4. 
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Figure 4.5. Wnt signaling is activated in response to culture with CHIR during directed differentiation. 
(a) Kinetic analysis of Log2 expression of putative Wnt reporter genes from Day 0 to 
Day 28 of human iPSC differentiation analyzed by Affymetrix microarrays. Error bars 
represent mean ± S.D, n = 3 biological replicates. (b) Map of EF1α-mCherry and Ef1α-
β-cateninΔGSK-SV40-mCherry lentiviral constructs. (c)  Fold change of mRNA 
expression in Day 19 NKX2-1GFP+mCherry+ cells infected on Day 15 with EF1α-
mCherry or Ef1α-β-cateninΔGSK-SV40-mCherry expression and treated with and 
without CHIR from Day 18 to 22. Fold change measured over undifferentiated iPSCs by 
RT-qPCR (2-ΔΔCt). Bars represent mean ± S.D., n=3. * p ≤ 0.05, *** p ≤ 0.001 by 
unpaired, two-tailed Student’s t-test. (d) Map of 7XTCF-mCherry lent rival reporter 
containing 7-TCF binding sites and a minimal thymidine kinase (TK MinP) promoter 
driving mCherry expression. (e) Representative images of 7XTCF-mCherry expression in 
FG293s treated with indicated doses of CHIR99021 for 48 hours. 
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Figure 4.6. Wnt signaling manipulation post-lung specification of human iPSCs.  
(a) Schematic of Wnt signaling manipulation at different stages of the lung differentiation 
protocol. (b) Kinetic of NKX2-1GFP expression in the presence (blue) and absence (black) 
of CHIR from Day 6 to 19. Cells analyzed on Days 17 and 19 were cultured without 
CHIR from Day 6 to 15. (c)  Quantification of 7XTCF-mCherry lentiviral reporter 
expression by flow cytometry from Day 6 to 15 in the presence (red) and absence (black) 
of CHIR. To control for viral infection efficiency, the percentage of 7XTCF-mCherry 
positive cells was normalized to the percentage of constitutive eEF1a-mCherry+ cells in a 
parallel well. (%7xTCF-mCherry+ / %Ef1a-mCherry+) (d) Representative images of 
7XTCF-mCherry and Ef1a-mCherry infected cells at day 6 (pre-CHIR treatment) and day 
8 (post-CHIR treatment) of differentiation. (e) Schematic of experiments manipulating 
Wnt signaling post-specification (f) Change in median fluorescence intensity (ΔMFI) 
between cells treated with and without CHIR from day 15 to day 19. Cells were infected 
with the 7XTCF-mCherry reporter and separate controls infected with EF1a-mCherry at 
the same multiplicity of infection. Bars represent mean ± S.D, n = 3 biological replicates. 
MFI was calculated from cells subgated for NKX2.1GFP expression. (g) Fold change of 
mRNA expression for 15 most upregulated and 15 most downregulated genes in 
NKX2.1GFP+ cells at Day 15 compared with Day 19 sorted NKX2.1GFP+ cells cultured 
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without CHIR from Day 15 to 19.  Values represent normalized RT-qPCR expression (2-
ΔΔCt method) to Day 15 cells. 
Next, we compared the stage-dependent effects of Wnt signaling pre- vs post-lung 
specification in our directed differentiation model using both CHIR and recombinant 
Wnt3a (Figure 4.6a). Cells differentiated from anterior foregut endoderm in the presence 
of CHIR expressed significantly higher levels of NKX2-1GFP as early as 48h after the 
initiation of specification in comparison to cells cultured without this compound, and this 
difference was maintained until at least day 15.  NKX2-1GFP expression could not be 
rescued in cells differentiated without CHIR to day 15 by later addition of this molecule 
suggesting that this effect was restricted to a narrow developmental stage (Figure 4.6b). 
Activation of canonical Wnt signaling in response to CHIR at these time points was 
further verified using lentiviral TCF-driven reporters, and conditions without CHIR again 
exhibited minimal, if any, basal Wnt activity (Figure 4.6c-d). Together, these results 
support the conclusion that canonical Wnt activity is required for in vitro specification of 
human lung epithelial progenitors, and that this effect is limited to a narrow window of 
developmental competence. 
CHIR Withdrawal Post Lung Epithelial Specification Results in Loss of Distal Lung 
Patterning and the Emergence of Proximal Lung Lineages, Including NKX2-1+P63+ 
Basal-Like Cells 
Next we tested the effect of sustained vs withdrawn Wnt signaling on the 
differentiation repertoire of hPSC-derived NKX2-1+ lung progenitors after lung lineage 
specification. We treated cells post-specification with CHIR, recombinant mouse 
Wnt3a165, or neither in a base media of 10 ng/mL FGF10 from day 15 to day 19 (Figure 
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4.4b, Figure 4.6e). To ensure that CHIR withdrawal correlated with expected decreases in 
canonical Wnt signaling activity, we confirmed reduced lentiviral TCF-driven reporter 
expression by day 19 (Figure 4.6f) as well as reduced expression of the Wnt signaling 
responsive genes LEF1, NKD1, and AXIN2  (Figure 4.4c). In addition, an unbiased 
comparison between NKX2-1GFP+ cells at day 15 and at day 19 after culture without 
CHIR using a Wnt pathway-specific qRT-PCR array confirmed this finding (Figure 
4.6g).  
Within 4 days withdrawal of CHIR resulted in significant changes in gene expression 
suggesting emergence of a proximal airway phenotype concordant with loss of distal cell 
fate in NKX2-1GFP+ cells. Specifically, proximal airway markers SCGB3A2, TP63, and 
MUC5AC were all upregulated and distal markers SOX9 and ETV5166 were 
downregulated in response to CHIR withdrawal (Figure 4.4d). Proximal airway 
patterning of individual NKX2-1+ cells in response to CHIR withdrawal was validated at 
the protein level by both immunofluorescence microscopy and flow cytometry. Triple 
immunostaining for NKX2-1, SOX2, and SOX9 nuclear proteins demonstrated that 
>90% of NKX2-1+ cells were SOX9+ in the presence of sustained CHIR, whereas 4 days 
after the withdrawal of CHIR, <40% of NKX2-1+ cells maintained detectable SOX9 
staining (Figure 4.4e-f). Although NKX2-1+ cells in both conditions contained >50% 
SOX2+ cells, CHIR withdrawal resulted in a significantly higher percentage of cells 
coexpressing NKX2-1 and SOX2 and a concordant absence of SOX9 in the majority of 
these NKX2-1+/SOX2+ cells (Figure 4.4e-f, Figure 4.7a). This result further revealed a 
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number of cells in both outgrowth conditions simultaneously expressing NKX2-1, SOX2, 
and SOX9 (Figure 4.7b). 
Furthermore, CHIR withdrawal resulted in increased frequencies of cells co-
expressing NKX2-1 and P63 (Figure 4.4g-h) and a subset of cells co-expressing NKX2-1, 
P63, and K5, a triad unique to airway basal cells (Figure 4.4i)60,167. Cells treated with 
rhWnt3a during this same window showed a milder distal patterning response relative to 
CHIR treatment (Figure 4.4c-d) with only partial activation of canonical Wnt activity 
detected as measured by AXIN2 expression, concordant with the previously reported 
low-level response of human cells to in vitro treatment with recombinant Wnt155.  
CHIR Acts Intrinsically on the Epithelium to Pattern Early Lung Progenitors 
Withdrawal of CHIR from day 15 to 19 resulted in a significantly decreased percentage 
of NKX2-1GFP+ outgrowth cells by day 19 (Figure 4.7c-d), raising the question of 
whether non-lung lineages were outcompeting lung lineages in the absence of sustained 
Wnt, and potentially contributing to secondary patterning effects in the NKX2-1+ 
population. We therefore sought to test whether the effect of CHIR manipulation on 
proximodistal lung patterning was intrinsic to lung epithelial cells rather than due to 
secondary or bystander effects. We used FACS to purify NKX2-1GFP+  epithelial lung 
progenitors at day 14 and replated them in three-dimensional (3D) culture with or without 
CHIR (Figure 4.8a) added to a base media (“DCI”) we have previously published as 
supporting epithelial gene expression in sorted NKX2-1GFP+ PSC-derived cells129,135 (also 
detailed in Hawkins et al., in press136). By day 20, the sorted cells formed small spheres 
coexpressing NKX2-1 and EPCAM (Figure 4.8b-c). >90% of all outgrowth cells in either 
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culture condition maintained NKX2-1GFP expression (+CHIR: 98.2±0.5% -CHIR: 
93.4±2.3%) (Figure 4.8d-e) and cells in each condition formed organoids with no 
measured statistical difference in efficiency. Analysis of re-sorted NKX2-1GFP+ cells at 
day 20 demonstrated withdrawal of Chir resulted in downregulation of Wnt pathway 
markers and concurrent upregulation of proximal lung genes SOX2, SCGB3A2, and 
TP63, and downregulation of distal lung genes SOX9 and ETV5 (Figure 4.8f). These 
results suggested that Wnt signaling levels regulate proximodistal patterning of NKX2-
1+ lung progenitors via intrinsic actions on the epithelium.  
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Figure 4.7. Lung progenitors differentially express patterning markers in response to CHIR treatment. 
(a) Immunofluorescence staining of NKX2-1, SOX2, and SOX9 nuclear protein and 
DNA (Hoescht) in cells treated with (+CHIR) and without (-CHIR) CHIR for 4 days 
post-specification (day 14-18). Scale bars, 25 µm (b) Immunofluorescence staining 
panels from stain performed in (a) with analysis of SOX2 and SOX9 coexpression. 
Arrows represent NKX2-1+ cells expressing both SOX2 and SOX9 nuclear protein. Scale 
bars, 25 µm (c) Representative flow cytometry analysis of NKX2-1GFP expression in 
CHIR and control conditions. (d) Quantification of NKX2-1GFP expression at Day 15 
(n=4) and Day 19 with and without CHIR99021 (n=10). Error bars represent mean ± 
S.E.M. *** p = 0.0004 by paired, two-tailed Student’s T-test. 
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Figure 4.8. Inhibition of proximal patterning by Wnt activation is intrinsic to the NKX2-1+ lung epithelium.  
(a) Schematic depicting experimental design testing CHIR effects on purified NKX2-
1GFP+ endodermal lung progenitors. (b) Full focus live cell fluorescence microscopy on 
day 20, depicting NKX2-1GFP expression in iPSC-derived organoids treated with and 
without CHIR from day 14-20 (6 days post-sort). Scale bars: Left and center panels: 100 
µm; Right panel: 25 µm. Dashed boxes in center panel represent area magnified in right 
panel. (c) Representative whole-mount immunofluorescence images of EPCAM (red) and 
NKX2-1 (green) expression in day 20 organoids. Scale bars, 25 µm (d) Representative 
NKX2-1GFP flow cytometry analysis of organoids on day 20. (e) Quantification of flow 
cytometry analysis from (d). Bars represent mean ± S.D., n=3. (f) Fold change of Wnt 
pathway and proximal and distal lung epithelial marker gene expression in NKX2-1GFP+ 
cells on day 20 over undifferentiated iPSCs by RT-qPCR (2-ΔΔCt). Bars represent mean ± 
S.D., n=3 biological replicates from independently sorted wells of a differentiation. * p ≤ 
0.05, ** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001 by unpaired, two-tailed Student’s t-test. 
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Recombinant Wnt3a promotes Sftpc expression and inhibits proximalization in Nkx2-1+ 
mouse ESC-derived lung progenitors 
Next we sought to test whether the patterning response to canonical Wnt signaling 
is conserved in other mammalian PSC model systems known to respond directly to Wnt 
ligands. As we have previously described the use of Wnt3a to drive lung differentiation 
in murine PSCs129,135 (Figure 4.9a) and because genetic mouse models demonstrate a role 
for canonical Wnt signaling in proximodistal patterning, we differentiated a mouse 
embryonic stem cell (mESC) line that contains an mCherry reporter targeted to the Nkx2-
1 locus 135,168 (Figure 4.9b). Following lung lineage specification into Nkx2-1+ 
primordial progenitors, on day 14 we replated sorted Nkx2-1mCherry+ vs Nkx2-1mCherry- 
cells (Figure 4.9c) for further differentiation in sustained vs withdrawn Wnt3a protein. By 
transducing these cells with a reporter lentivirus we have engineered to carry a human 
SFTPC promoter driving GFP expression129, we then screened for the emergence of lung 
cells expressing this canonical distal epithelial differentiation marker (Figure 4.9d). By 
day 18 we observed the emergence of many clusters of SftpcGFP+ cells deriving from 
mCherry+ sorted progenitors cultured in the presence of Wnt3a, but few, if any, 
detectable clusters in the absence of Wnt3a (Figure 4.9e). As accurately predicted by the 
SftpcGFP reporter, Sftpc mRNA was expressed at high levels in the presence of Wnt3a and 
proximal lung marker Scgb1a1 expression was suppressed in these conditions. In 
contrast, in the absence of Wnt3a, Scgb1a1 expression was upregulated and Sftpc 
expression was almost entirely lost (Figure 4.9f), findings consistent with our human PSC 
model.  Importantly, no detectable GFP signal and no Sftpc or Scgb1a1 mRNA 
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expression was observed arising from outgrowth of the sorted mCherry negative 
population in any condition (Figure 4.9f). These results provide further evidence that 
canonical Wnt activation promotes the differentiation of distal lung epithelium from 
PSC-derived Nkx2-1+ lung progenitors while suppressing the proximal lung program and 
that this effect is conserved across species. 
Figure 4.9. Mouse embryonic stem cell (mESC)-derived Nkx2-1mCherry+ lung progenitors upregulate Sftpc in 
response to Wnt3a. 
(a) Schematic depicting directed differentiation of Nkx2-1mCherry+ cells from mESCs (b) 
Schematic of targeted Nkx2-1mCherry locus. (c) Representative flow cytometry plot with 
gates for day 15 mCherry+ vs - sort. (d) Schematic of SftpcGFP lentivirus. (e) 
Representative images showing induction of the SftpcGFP reporter in cells from the Nkx2-
1mCherry+ outgrowth treated with rmWnt3a. (f) Fold change of mRNA expression for Sftpc 
and Scgb1a1 in outgrowth of Nkx2-1mCherry+ vs Nkx2-1mCherry- cells sorted on day 15 and 
analyzed on day 30 by RT-qPCR (2-ΔΔCt; fold change compared to day 0 mESCs). Bars 
represent mean ± S.D., n=2 biological replicates. 
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Derivation of Proximal Airway Organoids from Purified PSC-Derived Lung Epithelial 
Cells 
Having demonstrated that Wnt manipulation acts intrinsically on NKX2-1+ lung 
epithelium to induce rapid changes in proximodistal patterning, we sought to develop a 
“low-Wnt” protocol for the reproducible and efficient generation and maturation of 
functional proximal airway organoids from patient-specific lines for the purposes of 
disease modeling and the testing of gene therapies. Our results from 2D mESC 
differentiations (Figure 4.9) indicated that media containing FGF2 and FGF10 (“2+10 
media”) to broadly ligate FGF receptors would drive proliferation of sorted NKX2-1GFP+ 
lung progenitors while allowing proximal patterning, results in keeping with our 
previously published use of 2+10 media129. We therefore tested whether in 3D conditions 
2+10 media without CHIR or Wnt3a would result in proliferation and differentiation of 
proximalized human lung epithelial spheres in comparison to previously published high-
Wnt media containing CHIR as well as FGF10, and KGF ("CFK media") 
145 (Figure 4.10a). 
To ensure that organoids originated from an NKX2-1+ progenitor population, 
sorted NKX2-1GFP+ cells were replated and cultured in both “high Wnt” and “low Wnt” 
conditions in 3D. Cells in both conditions initially proliferated and formed epithelial 
spheres that maintained variable levels of NKX2-1 expression (Figure 4.10b-c). 
However, the spheres that formed in low-Wnt media expressed significantly higher levels 
of proximal airway genes than cells in high-Wnt media, including TP63, SCGB3A2, 
SCGB1A1, MUC5B, CFTR, FOXJ1, and SFTPB (Figure 4.10d). Although SFTPB has 
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previously been referred to as a marker specific to type II pneumocytes, it is also highly 
expressed in the developing human airway epithelium169,170. In contrast, cells cultured in 
high-Wnt media again expressed lower levels of proximal lung markers and higher levels 
of distal lung markers ETV5 and SFTPC (Figure 4.10d). Expression of additional distal 
alveolar epithelial markers, ABCA3 and LPCAT1, was also detected in cells cultured in 
high-Wnt media (data not shown.) 
Airway-like epithelial identity of the low-Wnt outgrowth was supported by 
immunostaining revealing luminal organoids where all cells expressed EPCAM and 
SOX2 and subsets expressed markers of secretory (SPB+/NKX2-1+; SCGB3A2+/NKX2-
1+), goblet (MUC5AC+NKX2-1-) and basal (NKX2-1+/P63+/KRT5+) lung lineages 
(Figure 4.10f-g, Figure 4.11a-f). These spheres were initially primarily secretory and 
basal in nature and exhibited low levels of FOXJ1 expression with no observed formation 
of multiciliated structures. However multiciliated epithelial cells with upregulated 
FOXJ1, downregulated SCGB1A1, and beating motile cilia could be generated from 
these proximalized epithelial spheres within two weeks either in continued 3D culture in 
the presence of Notch inhibition with DAPT79(Figure 4.10h)  or after transfer into 2D 
conditions in air liquid interface culture (Figure 4.10i and Figure 4.11g). 
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Figure 4.10. Generation of iPSC-derived airway organoids via purified NKX2-1+ lung progenitors. 
(a) Schematic depicting protocol for differentiating proximal and distal organoids from 
purified NKX2-1GFP+ progenitors. (b) Representative fluorescence microscopy for 
NKX2-1GFP expression in organoids cultured in distalizing (Wnt-high; CFK+DCI vs 
proximalizing (Wnt-low; 2+10+DCI) conditions until day 27. Scale bars, 50 µm. (c) 
Quantification of NKX2-1GFP expression in CFK+DCI and 2+10+DCI organoids at day 
27 by flow cytometry. Bars represent mean ± S.E.M., n=6. (d) Fold change of mRNA 
expression in day 27 organoids, and adult lung control over undifferentiated iPSCs by 
RT-qPCR (2-ΔΔCt). Bars represent mean ± S.E.M., (continued on next page) 
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n=6 biological replicates from independent wells of multiple differentiations. * p ≤ 0.05, 
** p ≤ 0.01, *** p ≤ 0.001, **** p ≤ 0.0001 by unpaired, two-tailed Student’s t-test. (e) 
Hematoxylin staining of  sectioned organoid. (f-g) Representative whole mount 
immunofluorescence staining for NKX2-1, F-actin (phalloidin), SOX2, SFTPB, 
SCGB3A2, MUC5AC, P63 and KRT5. Scale bars, 25 µm. (h) Fold change of mRNA 
expression in 2+10+DCI organoids cultured with DAPT or vehicle alone for 2 weeks 
(days 31-45). Bars represent mean ± S.D., n=3 biological replicates from one 
differentiation, *p ≤ 0.05 by unpaired, two-tailed Student’s t-test. (i) Representative z-
projection and orthogonal projections of acetylated alpha-tubulin and f-actin staining of 
9-day air-liquid interface culture generated from replated outgrowth of proximalized 
organoids. Upper panel, sc=25µM; lower panel, sc=10µM. (j) Schematic depicting 
proposed pathways for the generation of proximal or distal lung lineages from purified 
hPSC-derived lung progenitors. 
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Figure 4.11. Characterization of hPSC-derived proximal organoids.  
(a-d) Single channel fluorescence images of organoid immunostains for NKX2-1 with co-
staining for: (a) EPCAM (b) SOX2 (c) P63 (d) SPB (e) SCGB3A2 and (f) MUC5AC and 
DNA (Hoescht). Scale bars, 25 mm. (d) Representative z-projection of ALI 
differentiation stained for acetylated alpha tubulin and F-actin. Left panels, sc=25 mM; 
right panel, sc=10 mM 
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Taken together, these results suggested the proximalized airway spheres generated 
in low-Wnt conditions resemble airway epithelium and provide a mechanistic roadmap 
by which hPSC-derived NKX2-1+ lung progenitors can be differentiated to diverse 
lineages of distinct clinical interest (Figure 4.10j). In particular, identification of Wnt 
signaling as a key regulator of proximodistal patterning is a critical step for the rapid and 
reproducible generation from hPSC lines of proximal lung epithelial NKX2-1+/SOX2+ 
progenitors and their downstream basal, secretory, or multiciliated progeny. 
CFTR-Dependent Forskolin Swelling of Proximalized Organoids 
To test whether the organoids differentiated in our proximalized lung protocol contained 
functional epithelia of potential clinical benefit for cystic fibrosis disease modeling, we 
next sought to develop an in vitro quantitative assessment of epithelial CFTR function 
using patient-specific iPSC-derived airway organoids. It has been previously reported in 
non-lung systems that the activation of adenylyl cyclase by forskolin induces CFTR-
dependent organoid swelling, providing a robust and quantifiable in vitro functional 
readout of this ion channel171. To initially test whether our airway organoids swell in 
response to forskolin treatment, we differentiated iPSCs derived from either a healthy 
individual (BU3) or 2 individuals with cystic fibrosis due to homozygous ΔF508 CFTR 
mutations (RC2 202 and RC2 204). To purify NKX2-1+ primordial lung progenitors 
without requiring NKX2-1GFP knock-in reporters, we used the cell surface markers CD47 
and CD26 to isolate CD47hiCD26lo cells that are highly enriched in NKX2-1+ progenitors 
by day 15 from all 3 lines (Figure 4.12a)136. Importantly, sorted progenitors from all lines 
replated from day 15 to 22-35 showed a similar proximalized patterning response to 
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withdrawal of CHIR and expansion in 2+10 media as our C17 NKX2-1GFP targeted line 
(Figure 4.12b and data not shown), suggesting that this protocol reproducibly generates 
airway organoids from lung progenitors derived from different hPSC lines purified using 
cell surface marker sorting. 
By time lapse microscopy after exposure to forskolin we detected organoid 
swelling in the BU3 line within 3 hours and swelling continued for at least 20 hours (2.07 
+/- 0.6 fold at t=20 hours, Figure 4.12c-d). In contrast little, if any, swelling was observed 
in either cystic fibrosis line (RC2 202 or RC2 204) after exposure to forskolin or in BU3 
organoids stimulated with carrier vehicle alone (PBS only: 1.02 +/- 0.03, Figure 4.12c-d). 
Having observed forskolin-responsive swelling in normal and not cystic fibrosis patient-
derived proximalized organoids, we sought to establish whether this response was CFTR-
dependent. To test this, we used gene edited clones we have previously generated from 
both cystic fibrosis lines159 where one ΔF508 mutant allele has been corrected to wildtype 
sequence159. To compare the two diseased (ΔF508/ΔF508) iPSC lines to their syngeneic 
heterozygous corrected progeny (ΔF508/WT), we differentiated all 4 clones to the lung 
progenitor stage (Figure 4.13a) and purified each differentiated line using our 
CD47hi/CD26- sort algorithm (Figure 4.13b) and differentiated the organoids further in 
our “low-Wnt” media (Figure 4.13c). After proximalization, the gene corrected 
ΔF508/WT RC2 202 and 204 organoids significantly swelled in response to forskolin 
treatment (1.73 +/-0.15 fold and 1.32 +/- 0.09 fold, respectively). These values are 
comparable to swelling observed in wild type (BU3) organoids (Figure 4.12d). In 
contrast, the ΔF508/ΔF508 homozygous parental lines again showed no significant 
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swelling in the same conditions (Figure 4.12e and Figure 4.13d-f) Taken together, these 
results support the conclusion that proximalized iPSC-derived lung organoids contain 
functional epithelial cells with the potential for in vitro lung-specific disease modeling 
and gene correction of cystic fibrosis.  
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Figure 4.12. Forskolin swelling of hPSC-derived proximal airway organoids.  
(a) Representative day 15 CD47hi/CD26- sort gate from normal control (BU3) iPSC line 
(b) Fold change of mRNA expression in Day 34 2+10+DCI, CFK+DCI organoids 
derived from BU3 iPSC line, and adult lung control over undifferentiated iPSCs by RT-
qPCR. Bars represent mean ± S.E.M., n=3. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 by 
unpaired two-tailed Student’s t-test. (c) Calcein green and phase images of swelling in 
proximalized iPSC-derived organoids from a normal donor (continued on next page) 
		
103 
in response to carrier vehicle (PBS) or 5 mM forskolin from time = 0 hours to 20 hours. 
Arrows indicate organoids with robust, visible swelling. (d) Quantification of normalized 
swelling area of Day 38 organoids derived from a normal donor iPSC line treated with 
PBS or forskolin for 20 hours. Area was calculated from phase contrast images where the 
total well area of time=0 was set equal to 1 for each condition. Bars represent mean ± S. 
D., n=2. (e) Quantification of normalized swelling area of Day 22 organoids derived from 
pre- and post-corrected clones (RC2 204)at time = 0 hours (black) and time=24 hours 
(grey). Area was calculated where the calcein green positive well area of time = 0 hours 
was set equal to 1 for each line tested. Bars represent mean ± S.D., n=3. p = 0.0131 by 
unpaired, two-tailed Student’s t-test. 
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Figure 4.13. Functional assessment of gene edited, cystic fibrosis patient-specific iPSC-derived airway organoids 
indicates a CFTR-dependent forskolin swelling response.  
(a) Schematics depicting the generation, gene correction, and differentiation of syngeneic 
ΔF508/ΔF508 and ΔF508/WT cystic fibrosis patient-derived hPSC lines. (b) 
Representative flow cytometry analysis of intracellular NKX2-1 expression pre- and 
post-CD47hi/CD26- sorting of uncorrected and corrected cystic fibrosis iPSC line RC2 
204. Middle plots show typical CD47/CD26 sort gating strategy. (c) Schematic 
describing post-sort outgrowth of differentiated cells. (d) Fluorescence microscopy of 
live (calcein green stained) organoids from pre- and post-corrected iPSC line RC2 202 at 
time = 0 hours and time=24 hours post-forskolin treatment. Scale bars, 100 µm (e) Time 
lapse phase contrast microscopy of forskolin treated, gene corrected (ΔF508 / WT) 
organoids from RC2 204. (f) Quantification of normalized swelling area of organoids 
derived from pre- and post-corrected clones of RC2 202 at time=0, 3, and 25 hours. 
Calcein green stained area for each well set to 1 at time=0 hours. Bars represent mean ± 
S.D., n=3 biological replicates from independent wells of a differentiation. p = 0.0038 by 
unpaired, two-tailed Student’s t-test. 
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IV.4. Discussion 
Our results demonstrate the directed differentiation of pluripotent stem cells into 
functional airway epithelial cells via an NKX2-1+ progenitor intermediate in response to 
cyclical modulation of developmental signaling pathways. Using genetic mouse models 
to inform pathway screening during a narrow 4-day window post-lung specification, we 
identified Wnt signaling as a potent and key regulator of proximodistal patterning in both 
human and mouse PSC-derived lung epithelium. Our in vitro findings significantly 
extend prior observations made in mice in vivo 20,25-37, and suggest that developing 
human airway epithelia are similarly patterned by oscillations in levels of canonical Wnt 
signaling172. For example, prior published mouse studies emphasize a requirement for 
Wnt signaling during the narrow developmental window of lung specification21,22 
followed by alterations in Wnt signaling levels to regulate proximodistal patterning. In 
particular, it has been demonstrated that Wnt inhibition in mice promotes increases in 
proximalization at the expense of distal lineages20,27,42. In contrast, forced activation of 
Wnt signaling maintains distal lung progenitor programs while suppressing 
proximalization25,153. In some models, forced hyperactivation of canonical Wnt signaling 
during mouse lung development blocks club cell differentiation25 or activates aberrant 
gastrointestinal gene expression programs in the lung epithelium19. Interestingly, Wnt 
activation or inactivation in post-natal proximalized mouse lung epithelia does not result 
in loss of patterning26,54 in the absence of injury, but has been correlated with airway 
epithelial dysregulation in adult human smokers 173, suggesting that this pathway may 
have important alternative roles after development of airway lineages. 
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Similarly, we find that although Wnt signaling is essential for specification of 
respiratory progenitors from hPSCs, withdrawal of Wnt post-specification promotes rapid 
emergence of the proximal airway program and abrogation of distal lung fate via a 
mechanism intrinsic to the NKX2-1+ epithelium. This latter finding is critical, as 
previous genetic mouse models have emphasized both patterning and epithelial branching 
morphogenesis defects in the context of abnormal Wnt signaling. In contrast, our model 
provides interrogation of epithelial-specific effects of Wnt signaling distinct from defects 
in lung structure or branching.  
The rapidity and stage-specificity of Wnt-driven proximodistal airway patterning 
strongly supports our interpretation that temporal oscillations in signaling pathway 
activation are a critical component of effective directed airway differentiation. This result 
is in contrast to previous reports by Konishi et al. where purified lung epithelial 
progenitors differentiated from iPSCs were cultured in CHIR99021 prior to further 
differentiation in proprietary PneumaCult ALI media (from StemCell Technologies) that 
likely does not contain CHIR or any Wnt activatior147,148 to generate proximal airway. 
Using this approach, Konishi et al. generate functional multiciliated cells in the presence 
of Notch inhibitor DAPT. However, it is worth noting that Konishi et al. track SOX2 as a 
marker of early proximal airway progenitor differentiation; however, we observe high 
levels of SOX2 expression in this study even in CHIR condition media, although they are 
lower than in conditions where CHIR is withdrawn. Furthermore, we find that expression 
of SOX9 is much more predictive of distal vs. proximal fate than SOX2, in particular due 
to the presence of SOX2+SOX9+ cells (in particular in the distal +CHIR condition). 
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Taken together, these ideas suggest that Konishi et al. is not in conflict with our result but 
that their conclusion that proximalization is occurring in the presence of CHIR is likely a 
misinterpretation of the specificity of the SOX2 marker for proximal lung. Furthermore, 
while they do generate proximal airway in their final protocol, their differentiation relies 
on extended culture periods and late Wnt withdrawal in the PneumaCult ALI media 
condition. Further experiments from our group will seek to understand how the timing of 
Wnt withdrawal post-specification can change the proximal vs. distal patterning and 
eventual fate of derived cells.  
We therefore conclude from our results that our approach is faster, more robust, 
and allows for the generation of intermediate populations that are more similar to early 
airway cells (e.g. NKX2-1+SOX2+SOX9-P63+ cells) than any previously described 
approach and suggest that the generation of these cell types will allow for future work 
(e.g. generating approaches to study complex developmental lung diseases) to be based 
on a more relevant cell population.  
Therefore, we built on our findings about the proximal patterning of iPSC-derived 
lung in response to Wnt withdrawal by generating a  novel “low-Wnt” protocol presented 
here for the derivation of airway organoids from purified NKX2-1+ lung epithelial 
progenitors. Three key features of our approach are unique. First the use of an NKX2-
1GFP knock-in reporter has allowed us to dissect lineage relationships, establishing that 
our proximal airway epithelia derive directly from an NKX2-1+ lung progenitor 
intermediate. Second, the ability to modulate Wnt signaling in these purified NKX2-1+ 
“epithelial only” derivatives allows testing of intrinsic pathway effects separated from the 
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potentially confounding responses of mesenchymal or other NKX2-1- lineages that are 
frequently present in unsorted heterogeneous PSC experiments. Third, the rapid, 
patterned response of our sorted lung progenitors to withdrawal of Wnt (augmented 
proximalization concordant with loss of distalization within 4 days) suggests that directed 
developmental patterning is occurring rather than the overgrowth of competing proximal 
lineages that can occur with prolonged culture periods. While we cannot completely 
exclude the possibility that selection of lineage restricted cells, rather than the patterning 
of bipotent or equipotent NKX2-1+ day 15 progenitors is occurring in our protocol, the 
rapidity of the large scale changes in SOX9 vs SOX2 expression patterns in response to 
Wnt withdrawal argues against this possibility. 
The end result of our approach is the production of a potentially inexhaustible 
source of human proximal airway organoids. These luminal structures contain multiple 
airway epithelial lineages and express airway markers at levels comparable to the adult 
lung. As predicted by murine models, inhibition of Notch signaling in these organoids or 
subsequent 2D air-liquid interface culture results in ciliogenesis in a subset of cells64 
146,147 and provides evidence for our conclusion that organoids grown from purified 
NKX2-1+ lung epithelial cells in the absence of CHIR represent true proximalized airway 
progenitors that respond as predicted to developmental signaling cues.  
One important goal of our work is the engineering of clinically applicable patient-specific 
in vitro models of airway epithelial disease and epithelial function. Thus, we have 
developed cell sorting algorithms (CD47hi/CD26-) that enable the isolation of iPSC-
derived NKX2-1+ lung progenitors possessing airway organoid competence without the 
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need to generate NKX2-1GFP knock-in reporters for each patient specific line to be 
studied. We employ this sorting algorithm and our proximalization approach to produce 
patient-specific airway epithelial organoids both before and after gene editing to correct 
the CFTR genetic lesion responsible for cystic fibrosis. These airway organoids allow for 
the first time in vitro forskolin stimulation assays to analyze CFTR function in lung 
epithelial cells, opening future avenues towards high-throughput drug screening in 
patient-specific airway cells. A logical priority in future studies will be testing whether 
our patient-specific airway organoid model of cystic fibrosis more closely recapitulates 
the known person-to-person variability in clinical disease phenotypes compared to 
previously published and more invasive models of CFTR function that are based on non-
lung cells, such as primary intestinal cell-derived forskolin-induced swelling assays171. 
Beyond cystic fibrosis, the iPSC airway organoid system may also be readily adaptable 
for in vitro modeling and drug development for other inherited diseases of the airway, 
such as primary ciliary dyskinesia. 
In summary, the findings presented here demonstrate the rapid generation of 
airway organoids by stage-dependent modulation of Wnt signaling and proof-of-principle 
for the utility of these organoids in lung disease modeling. Thus we have developed a 
human in vitro PSC-based model system able to reveal basic mechanisms regulating lung 
developmental cell fate decisions and model airway epithelial diseases with potential 
clinical benefit for precision drug screening and regenerative medicine.   		
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V. GENERATION OF AN SCGB3A2-CHERRY hPSC REPORTER TO TRACK 
PROXIMAL LUNG DIFFERENTIATION 
NOTE: The generation of an SCGB3A2CherryPicker CRISPR/Cas9 system was 
performed in collaboration with Edward E. Morrisey and his laboratory at University of 
Pennsylvania, Philadelphia, PA. 	
V.1. Rationale 
Many chronic lung diseases, such as COPD and asthma, involve changes in the 
cellular composition and identity of the airway epithelium. Improved models to study the 
normal, developing airway epithelium may therefore provide some insight into the 
etiology of these complex diseases. As we have previously described a protocol for 
rapidly and efficiently generating proximal lung organoids from pluripotent stem cells 
(see Chapter IV) but still poorly understand the identity of these early airway cells and 
how they differentiate and develop, we sought to build a model that would allow us to 
interrogate and track these cells more precisely. We therefore generated a reporter hPSC 
line to track, purify, and characterize cells undergoing airway differentiation. As 
SCGB3A2 is a highly and consistently upregulated gene in response to proximalization 
of lung progenitors, we chose this gene as the readout for our reporter system. 
Here, we describe the generation of a SCGB3A2CherryPicker reporter hPSC line, 
which faithfully enriches differentiated proximal lung organoids for a population 
expressing SCGB3A2 as well as markers of diverse airway lineages. This early work 
suggests that this reporter will facilitate studies of a number of cell types of distinct 
functional relevance. We have therefore built a system that we will use in ongoing studies 
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to track the development of the proximal airway in vitro and perform a detailed 
interrogation of this epithelium, paving the way for new models of complex airway 
diseases involving perturbations in cell fate.  
V.2. Materials and Methods 
Some methods used to generate the results in this section, including 
immunofluorescence, quantitative real time PCR, maintenance of undifferentiated cells, 
and directed differentiation of hPSCs to NKX2-1+ lung epithelium, are described in 
Chapter III and Chapter IV. 
Generation of knock-in reporter hPSC line using CRISPR/Cas9 
A guide RNA targeting the stop codon of the SCGB3A2 gene was designed and 
cloned into the pSpCas9(BB)-2A-GFP plasmid, a gift from Feng Zhang (Addgene 
plasmid #48138), using standard techniques outlined at www.genome-
engineering.org/crispr. 
Together with the pSpCas9/gRNA plasmid, a donor vector containing homology 
arms to the third exon and the 3’UTR of the SCGB3A2 gene, P2A-CherryPicker, and a 
loxP-flanked Neomycin resistance cassette was transfected into undifferentiated RUES2 
(generous gift from Dr. Ali H. Brivanlou  of The Rockefeller University) human 
pluripotent stem cells maintained on mTeSR (Stem Cell Technologies) by nucleofection 
using the Lonza P1 System. Further details of the targeting vector used are detailed in 
Figure 5.1. 
Neomycin-resistant colonies were selected and, due to the expression of 
SCGB3A2 in undifferentiated cells, individual CherryPicker+ cells were sorted into each 
		
112 
well of a 96-well plate onto a MEF feeder layer to reduce mosaicism. Colonies were 
expanded clonally. Targeted cells were confirmed by PCR using primers binding within 
the CherryPicker region and outside of the 3’ homology arm of the donor template. 
In targeted clones, the neomycin resistance cassette was excised using 
lipofectamine to transfect a Cre-Puro plasmid and selecting for puromycin resistant 
colonies. Excision of the neomycin cassette was confirmed by PCR screening. Cre-
excised colonies were adapted to mTeSR culture and screened by pluripotency staining 
(ES Cell Characterization Kit, Millipore) and karyotype analysis (performed by Cell Line 
Genetics, Madison, WI). 
	
V.3. Results 
To generate an hPSC reporter line for developing airway lineages, we used 
CRISPR/Cas9 technology to target a CherryPicker fluorescent reporter to the SCGB3A2 
locus, summarized in Figure 5.1a. To accomplish the targeting, we used a two plasmid 
targeting strategy where we introduced to the human ESC line RUES2: 1) a 
CRISPR/Cas9 construct to introduce a double stranded break at the stop codon in the 
third exon of the native SCGB3A2 locus and 2) a donor construct containing arms of 
homology spanning the SCGB3A2 stop codon, which was replaced by a P2A self-
cleaving peptide and CherryPicker gene as well as a floxed neomycin resistance cassette 
for antibiotic selection of targeted clones. This cassette was later removed by transient 
overexpression of Cre recombinase. As a whole, this targeting strategy results in the 
recombination of the donor cassette into the native SCGB3A2 locus, resulting in 
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transcription and translation of the 3’UTR-targeted CherryPicker construct along with the 
SCGB3A2 protein before subsequent cleavage at the P2A peptide site. 
 
Figure 5.1. Targeting of SCGB3A2 reporter line 
a) Schematic showing CRISPR targeting strategy, including guide RNA site, screening 
primers, and donor template. After Cre excision of the targeted locus, the Neo resistance 
cassette is removed (continued on next page) 
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b) Gel of PCR confirming targeting using primers indicated in (a). Lengths indicated 
expected length of PCR product for targeted line based on DNA sequence. These results 
are from clones pre-Cre excision. c) Pluripotency staining of targeted, Cre excised line 
showing positive staining (green) for SSEA-4 and Tra-1-60 and negative staining for 
SSEA-1 overlayed with staining by Hoescht DNA dye (blue). d) Karyotypic analysis of 
targeted, Cre excised line indicating normal female karyotype. 
 
 
Using this approach, we targeted the human embryonic stem cell line RUES2  
(Figure 5.1b) and single-cell sorted antibiotic resistant colonies to derive a clonal 
population. One subclone of this line was selected and found to be pluripotent by staining 
for pluripotency markers SSEA-4 and Tra-1-60 (Figure 5.1c) and was karyotypically 
normal (Figure 5.1d).   
To test the differentiation of this line to airway progenitors, we used our 
previously published differentiation protocol to derive by day 15 NKX2-1+ lung 
progenitors at an efficiency of 60.4±10.7%. We enriched for NKX2-1+ progenitors to 
80.1±14-9% of the population using our CD47hi/CD26- sorting strategy and replated 
these sorted cells in three-dimensional organoid culture. To validate the fidelity of our 
reporter as a readout of proximalization, we compared the outgrowth of these progenitors 
in low-Wnt “proximal airway” media containing FGF2, FGF10, dexamethasone, cyclic 
AMP, and IBMX (2+10+DCI) vs. high-Wnt “distal lung” media containing CHIR, 
FGF10, KGF and DCI (CFK+DCI) (Figure 5.2a). SCGB3A2CherryPicker expression was 
observed in organoids cultured in proximal airway (Figure 5.2b), but not distal lung, 
media by day 23 of differentiation, and by day 25, 33.0±1.6% of cells in 2+10+DCI 
expressed SCGB3A2CherryPicker, in comparison to 0.1±0.03% of cells in CFK+DCI (Figure 
5.2c-d). 
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Figure 5.2. Directed differentiation of SCGB3A2CherryPicker line to airway lineages. 
a) Schematic of directed differentiation protocol to generate “distal” and “proximal” 
organoids from SCGB3A2CherryPicker (SCGB3A2CP) hPSC line. b) Micrograph of 
SCGB3A2CherryPicker expression overlayed on phase image of Day 23 proximalized 
(2+10+DCI) organoid. c)  FACS analysis of Day 25 “distal” (CFK+DCI) vs. “proximal” 
(2+10+DCI) organoids showing CherryPicker expression in the proximal protocol. d) 
quantification of FACS result in c. e) Fold change of lung marker mRNA expression in 
sorted SCGB3A2CherryPicker+ (SC+) and SCGB3A2CherryPicker- (SC-) cells on day 25 over 
undifferentiated iPSCs by RT-qPCR (2-ΔΔCt). Bars represent mean ± S.D, n=3. ** p ≤ 
0.01 by unpaired, two-tailed Student’s t-test. 
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To further understand the identity of this labeled population,  we purified the 
SCGB3A2CherryPicker+ and SCGB3A2CherryPicker- populations (hereafter SC+ and SC-) and 
asked whether the labeled cells were enriched for expression of markers of the proximal 
airway epithelium. SC+ cells expressed higher levels of SCGB3A2 and NKX2-1 as well 
as other secretory cell genes, including SCGB1A1 and SPB, than CP- cells. CP+ cells 
were additionally enriched for expression of basal cell (P63) and goblet cell (MUC5B) 
genes (Figure 5.2e).  Taken together, these results support our conclusion that our 
SCGB3A2 CherryPicker line labels a population of SCGB3A2+ proximal airway cells that 
may represent a single airway progenitor or a heterogenous mix of cells with different 
functions and identities.  
As SC+ cells seem to account for many of the known proximal lung lineages and 
we have previously shown that this protocol results in little to no distal lung 
differentiation (see Chapter IV), we next asked what the SC- population might represent, 
in particular in the context of our previous observations that there exists a population of 
NKX2-1- cells in our organoids, even after enriching at day 15 for NKX2-1+ lung 
progenitors. Although we have observed that some of these NKX2-1- cells are likely lung 
cell types (e.g. NKX2-1- goblet cells, see Chapter IV), we also wondered whether we 
could be observing the emergence of non-long lineages in our organoids. Since SC- cells 
are depleted for NKX2-1 expression relative to the SC+ population, we looked by qRT-
PCR for markers of non-lung endodermal lineages including liver (AFP), esophagus 
(PITX1) and gut (CDX2). We found that SC- cells were enriched for all three of these 
markers relative to SC+ cells (Figure 5.3). 
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Figure 5.3. SCGB3A2CherryPicker- cells express markers of non-lung endoderm. 
Fold change of endodermal marker mRNA expression in sorted SCGB3A2CherryPicker+ 
(SC+) and SCGB3A2CherryPicker- (SC-) cells on day 25 over undifferentiated iPSCs by RT-
qPCR (2-ΔΔCt). Bars represent mean ± S.D, n=3. 	
V.4. Discussion and Future Directions 
Our preliminary results demonstrate the generation of an SCGB3A2CherryPicker 
hPSC reporter line that enriches for markers of proximal airway cell types after directed 
differentiation. In particular, we have observed enrichment of an array of lung markers 
consistent with diverse airway cell types, such as SCGB1A1 (club cells), MUC5B (goblet 
cells) and P63 (basal cells).  
Building on this implied heterogeneity, our ongoing studies will seek to address 
whether SCGB3A2 in our in vitro human directed differentiation model marks an early 
“human airway progenitor” that may differentiate to a number of mature airway cell 
types or whether the individual SCGB3A2+ cells within the population we are studying 
are already differentiated. To begin to dissect this complex question, we will perform 
single cell RNA sequencing on an early (day 27) population of SCGB3A2+ cells and 
interrogate their statistical heterogeneity. We will further perform experiments purifying 
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SCGB3A2+ cells and replating them to test their differentiation potential to other lung 
lineages and address how it may change over time. 
In murine models, Scgb3a2 expressed primarily in the developing proximal 
airways from E12.5 – E18.5, where it is a marker of early Notch-mediated commitment 
to secretory (vs. ciliated) fate84. At later stages of development and in adult mice, 
Scgb3a2 also labels a subpopulation of Cc10low naphthalene-resistant adult club cells 
localized adjacent to neuroepithelial bodies69,84, which is in contrast to our finding that 
airway markers not typically expressed in club cells are enriched by our SCGB3A2 
reporter. With this in mind, we also plan to test whether SCGB3A2 expression becomes 
restricted to the club cell lineage at a later point of differentiation than our current studies 
have probed. 
Finally, the identification of non-lung markers in the sorted SCGB3A2- 
population has important implications for ongoing studies. Based on experiments where 
NKX2-1 enrichment was nearly 100% at day 15 and NKX2-1- populations still emerged, 
we hypothesize that not all day 15 NKX2-1+ cells are fully committed to the lung 
lineage, in spite of expressing this key transcription factor, and therefore “revert” to a 
non-lung lineage after sorting, and perhaps after the withdrawal of the strong Wnt 
activator CHIR99021. This idea is supported by mouse literature showing exogenous 
expression of NKX2-1 in non-lung lineages after overexpression of activated β-catenin19. 
We plan to more rigorously test this hypothesis using single-cell RNA sequencing, high 
purity cell sorting, and protein-level analysis of non-lung populations. In addition to 
further supporting the importance of using an airway cell reporter for downstream studies 
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to prevent making conclusions based on non-lung cells, this idea has important 
implications for studies of cell fate; it would therefore be of particular interest to 
interrogate the differences in “true” and “false” NKX2-1+ populations at day 15 for 
molecular differences between these cells, including epigenetic markers and transcription 
factor binding. 
 In summary, this preliminary data using our novel SCGB3A2CherryPicker reporter 
line has generated many questions about the development of the human airway 
epithelium and of lung cell fate. By building on these initial observations and generating 
novel tools to study secretory cell biology, we hope to generate additional insight into 
diseases that result in aberrant airway epithelial fate. 
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VI. GENERAL DISCUSSION 
This thesis describes the generation of both murine and human reporter 
pluripotent stem cell lines to track lung development and differentiation, builds on 
genetic mouse literature to establish a critical role for Wnt signaling in proximal lung 
development, and has described a roadmap towards the production of clinically relevant 
airway organoids for in vitro disease modeling and drug screening. 	
VI.1. Future directions 
Molecular and Developmental Biology of Cell Fate 
In spite of these advances, many complex questions still remain about the systems 
and findings described in this work.  In particular, much of the mechanistic molecular 
biology regulating cell fate decisions in lung development remains unexplored. In 
particular, the model presented in Chapter IV describing a role for Wnt signaling in 
proximal lung development is an ideal system to address questions about the molecular 
drivers of cell fate in lung development that have not yet been fully explored. For 
example, this work does not present an in-depth picture of the mechanisms by which Wnt 
signaling regulates proximal lung fate. Of particular interest to this process is the 
relationship between β-catenin and the key proximal transcription factor Sox2. Genetic 
mouse literature demonstrates, for example, that overdriving β-catenin in the airway 
epithelium results in loss of Sox2 in these cells25, providing an initial link between the 
potency of Wnt signaling as a driver of distal fate at the expense of the proximal 
epithelium and suggesting that further work to study the link between Sox2 and β-catenin 
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could provide critical insight into this complex relationship. In particular, the system 
developed in Chapter IV is particularly amenable to experiments testing whether Sox2 
and β-catenin interact directly in the early lung epithelium and whether the presence of 
either protein changes the binding targets of the other. This is of interest in part due to our 
finding in Chapter IV that SOX2 is expressed in a subset of SOX9+ cells after lung 
specification in the presence of Wnt activation, suggesting that this protein may have a 
different role in these cells than in their SOX9- counterparts. A related question is 
established by our finding that there is role of Wnt signaling both in specifying and 
patterning the lung epithelium, which naturally leads to the question: When do cells no 
longer require Wnt signaling to be “lung” but instead need it to drive distalization? 
Experiments testing the epigenetic state of the endoderm and lung epithelium throughout 
directed differentiation to establish a more rigorous molecular picture of cell fate during 
lung development are critical to beginning to understand this important finding.  
Related to this, there are also many fundamental questions about early patterning 
of hPSCs that remain unanswered. In particular, not only are there issues of putative 
“priming” of hPSCs to specific lineages during pluripotency, every stage of directed 
differentiation introduces possible patterning or heterogeneity that we currently do not 
understand. This is exemplified by the result that within differentiating cells that appear 
to be a homogenous population of  definitive endoderm, only a subset respond to Wnt, 
BMP4 and retinoic acid signaling to become lung epithelium. We currently do not know 
whether this is due to some intrinsic prepatterning of the early endodermal population or 
of an alternative effect, such as contact inhibition of differentiation due to cell density. 
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Relatedly, ongoing work in our group is trying to establish whether all of the 
NKX2-1+ lineages within our differentiation system are fully committed to lung. In 
Chapter V, I explore some evidence that withdrawal of Wnt activation from a pure 
NKX2-1+ population leads to loss of NKX2-1 fate and expression of markers of 
endodermal non-lung lineages, possibly because overstimulation of the Wnt pathway 
results in aberrant upregulation of NKX2-1, similar to what has been previously shown in 
vivo by Goss et al21. This question merits further exploration, some of which will be able 
to be accomplished with the reporter line described in Chapter V. 
Outside of Wnt signaling, other questions about the establishment of lung 
epithelial cell fate during development remain unexplored. For example, given a pool of 
Sox9+Id2+ early distal tip progenitors in the lung, how does a given cell eventually 
become airway whereas its neighbor in the distal tip becomes alveolar? The implications 
of this question are wide-reaching and could readily be further explored in a high-
resolution hPSC-based system: Do cells in the distal tip epithelium see the same signals 
and respond differently than their neighbor due to “prepatterning” of these cells or 
epigenetic effects, or are growth factor gradients the main driver of fate in this 
population? When do the proximal and distal lung really separate and specify from each 
other? Do these cells undergo asymmetric cell division to establish their fate? Careful 
single cell analysis and Sox2/Sox9 lineage tracing of early lung epithelium may help 
begin to answer some of these questions.  
One interesting insight from the result in Chapter IV is the absence in our work of 
any identified signaling pathway that drives cells towards a proximal fate; that is, cells 
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appear to undergo proximal differentiation in the absence of an exogenous signal other 
than a mitotic signal (e.g. FGF10) required to keep cells alive. This is in contrast to 
earlier reports from mouse models that there are pathways, including TGFβ (which had 
no reproducible patterning effect in our system), that are drivers, rather than inhibitors, of 
proximal lung patterning35,37. One interpretation of this result is that proximalization is a 
“default” fate that occurs in the absence of any exogenous stimulation. This echoes other 
areas of stem cell biology; for example, Ying et al. demonstrated that pluripotency in 
mouse ESCs is maintained independently of extrinsic factors103. Future studies in the 
lung epithelium, therefore, may benefit from further clarifying the mechanisms of 
proximal patterning and exploring the requirement for exogenous signaling to promote 
proximal lung patterning, in particular in epithelial-only systems as described in Chapter 
IV. 
The system described in this thesis may also help to clarify questions about the 
plasticity of the early lung. Much like the ongoing questions about how the early 
proximal and distal lung are separated, there is little knowledge of how and when cells 
become committed to the  proximal vs. distal lung during development. Initial 
experiments using mouse lung explant studies have demonstrated that early in 
development, recombination of proximal mesenchyme with distal epithelium and vice 
versa can change the proximal or distal fate of the epithelium, but that this potential is 
lost later in development39,40. A system where growth factor signaling can be rapidly 
manipulated at very short and defined temporal windows, such as directed differentiation, 
is an ideal way to look at this question in higher resolution. For example, one simple 
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approach would be to generate lineage tracing hPSC reporters for SOX2 and SOX9 and 
use these to track the competence and developmental potential of these lung lineages in 
different signaling contexts (e.g. with Wnt manipulation). This system could provide 
insight into the timing and context at which proximal vs. distal fate is “fixed” and, 
relatedly, allow for the exploration of the molecular and epigenetic signatures of this 
event. Finally, this could be combined with previous approaches to understand the DNA 
binding sites and interactions of SOX2 and SOX9 in different temporal and signaling 
contexts to further elucidate of the role of these transcription factors in development. 
Generation and Characterization of Proximal Lung Organoids 
In addition to new insights into molecular developmental biology, many questions 
remain unanswered about the proximal lung organoids generated here from pluripotent 
stem cells. In particular, in addition to the questions previously addressed regarding the 
loss of NKX2-1 expression after CHIR withdrawal, we still understand relatively little 
about the cells that comprise these epithelial organoids, how their identities are 
established, and how they interact with each other. We are beginning to explore these 
questions by developing reporter lines to track and purify important proximal lineages, 
such as the SCGB3A2 reporter cell line described in Chapter V as well as a P63 reporter 
that we will use to track basal cell differentiation. Of particular interest is understanding 
the hierarchy of the development of these proximalized airway cells: do all cells go 
through a P63+ or SCGB3A2+ intermediate stage? At what stage do basal-like cells 
emerge and mature? What other cell types exist within these organoids? Are all of them 
found in the native human lung, or are some “confused” cells? At what stage do secretory 
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vs. goblet cells, for example, separate and perform their own cellular functions (such as 
mucus secretion in goblet cells or differentiation to ciliated cells, toxicant processing, and 
secretory granule formation in secretory cells)? This latter point is critical; in addition to 
comparing the transcriptomic profiles of our cells with normal adult lung, pursuing these 
functional readouts will be an important measure of how close or far our hPSC-derived 
cells are from their in vivo counterparts. 
It is additionally worth noting that the “epithelial-only” organoids generated in 
this model likely lack many of the normal cues that help to define the lung epithelium and 
instruct its maintenance and composition. In particular, it is known that the structure and 
cell-cell interactions in the epithelial niche help to maintain the relative cellular 
composition of the epithelium, and it is likely that these interactions are somewhat 
disrupted in our organoid models. For example, that the normal proximal airway is 
primarily comprised of a pseudostratified epithelium with basal and luminal layers that 
interact with each other and help to instruct each other’s fate during normal homeostasis 
as well as in the context of injury62,63,75. We have not observed this structure or types of 
interactions in our organoid system, suggesting that this platform likely does not 
recapitulate all aspects of the in vivo lung in ways we do not fully understand.  
Related to this is the goal of generating a system that integrates the mesenchyme 
with the epithelium, as they exist in normal lung. This is a particularly important goal as 
we build models of diseases that are hypothesized to be initiated or perpetuated by 
interactions between the mesenchyme and the epithelium. For example, some genetic 
forms of idiopathic pulmonary fibrosis (IPF) caused by mutations in epithelial genes, 
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such as SFTPC174. As fibrosis involves the lung mesenchyme86 this suggests that there 
may be interesting interactions between the diseased epithelium and the surrounding 
mesenchyme that contribute to pathogenesis of IPF. This could potentially be modeled 
using epithelial-mesenchymal coculture models using hPSC-derived epithelium. This 
approach would be based off of organoid models where primary lung epithelial cells have 
been successfully combined with mesenchyme, such as those described in Lee et al175 
using organoid coculture of secretory cells and endothelial cells as a basis to study the 
mechanisms of epithelial-mesenchymal crosstalk in lung regeneration.  
 
VI.2. Broader clinical implications 
While there remains significant work to be done to fully understand and improve 
the generation of airway epithelium from hPSCs, the protocol to differentiate proximal 
lung organoids described in Chapter V has substantial implications for disease modeling 
and cell-based therapy, supported by the proof of principle example presented here of the 
use of these cells to model cystic fibrosis in vitro. 
Building on these initial studies, the promise of hPSC-derived airway organoids in 
in vitro assays is substantial: the ability to derive an inexhaustible source of proximal 
lung epithelium (as well as other cell types, e.g. gut, blood, or liver) from specific 
patients and to generate isogenic gene corrected controls hold promise for improved in 
vitro drug screening approaches both broadly and in the context of individually targeted 
therapeutics. Additionally, more complex future applications of these cells include 
studies looking at 1) how the lung is affected by multisystem disorders 2) what genetic 
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and molecular causes contribute to the heterogeneous presentations of disorders with a 
single genetic cause, and 3) how interactions between different organ systems (e.g. the 
lung and the immune system) contribute to disease pathogenesis.   
Finally, the eventual promise of lung cell types generated from induced 
pluripotent stem cells is in cell-based therapy using syngeneic patient-derived cells to 
avoid the need for immunosuppression post-transplantation. There are several possible 
approaches to this type of therapy, including de novo reseeding of decellularized lung 
scaffolding to generate a complete lung tissue176 and engraftment of in vitro derived 
airway cells directly into the damaged lung of a patient.  
One promising approach for disease modeling or cell-based therapy with hPSC-
derived airway epithelium is the tracheal xenograft model, which was initially developed 
to study the behavior of malignant airway cells177 but that has since been used as a 
popular model for tracheal regeneration and response to injury178. In this model, airway 
cells are used to reconstitute the epithelium of a denuded trachea that are transplanted 
into the flank of a mouse (in the case of human tracheal xenograft models, this is an 
immunodeficient SCID mouse). In addition to being used as a model for injury repair, 
this has also been used for diverse applications of disease modeling, including testing 
gene therapy for cystic fibrosis179. These studies are based on the reasonable premise that 
a cellular model that is structurally similar to the native trachea may recapitulate more 
precisely the functional phenotype of a normal epithelium and therefore may be an 
improved platform for disease modeling compared to in vitro approaches. This logic 
certainly applies to the hPSC-derived airway epithelial model as well, implying that a 
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tracheal xenograft approach may be a promising starting point to generate in vivo models 
using our cells.  
Recent work has also described the successful engraftment of primary mouse lung 
epithelial cells into the lungs of mice post-influenza infection180, a promising finding that 
provides an initial roadmap for testing the direct engraftment of our in vitro derived cells 
into recipient lungs without first needing to generate and transplant an ex vivo structure, 
such as a tracheal xenograft. Primarily, this work highlights the likely importance of 
“making space” for engraftable cells in the epithelium by damaging the native tissue prior 
to introducing new cells. However, the influenza injury induced by this model results 
primarily in damage to the distal epithelium. Other models of injury that cause damage 
more specifically to the trachea and upper airways, including sulfur dioxide (SO2), may 
be a better starting point for the engraftment of proximal lung cells in vivo than influenza 
injury. 
The field of engraftment directly into a damaged lung is still in its infancy; few 
reports of successful engraftment, even of in vivo-derived cells, have been substantiated. 
In contrast, the tracheal xenograft model has been in use for many years and may be more 
amenable to in vitro derived cells. Overall, developing and testing each of these models 
with hPSC-derived airway cells has the potential to be an important advance towards the 
use of hPSC-derived airway epithelium in clinical applications, both for cell-based 
therapy and building clinically relevant disease models.  	
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